novaccess20220331

0001185185-22-000616.txt : 20220516 0001185185-22-000616.hdr.sgml : 20220516 20220513184323 ACCESSION NUMBER: 0001185185-22-000616 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovAccess Global Inc. CENTRAL INDEX KEY: 0001039466 STANDARD INDUSTRIAL CLASSIFICATION: UNSUPPORTED PLASTICS FILM & SHEET [3081] IRS NUMBER: 841384159 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-29621 FILM NUMBER: 22924552 BUSINESS ADDRESS: STREET 1: 8584 E. WASHINGTON STREET, NO. 127 CITY: CHAGRIN FALLS STATE: OH ZIP: 44023 BUSINESS PHONE: (213) 642-9268 MAIL ADDRESS: STREET 1: 8584 E. WASHINGTON STREET, NO. 127 CITY: CHAGRIN FALLS STATE: OH ZIP: 44023 FORMER COMPANY: FORMER CONFORMED NAME: XSUNX INC DATE OF NAME CHANGE: 20031001 FORMER COMPANY: FORMER CONFORMED NAME: SUN RIVER MINING INC DATE OF NAME CHANGE: 20000218 10-Q 1 novaccess20220331_10q.htm FORM 10-Q novaccess20220331_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 000-29621

NovAccess Global Inc.

(Exact name of registrant as specified in its charter)

Colorado	84-1384159
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

8584 E. Washington Street #127, Chagrin Falls, Ohio 44023

(Address of principal executive offices)(Zip Code)

(213) 642-9268

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. There were 18,398,673 shares of common stock outstanding on May 13, 2022.

Table of Contents

PART I — FINANCIAL INFORMATION	1
Item 1. Financial Statements.	1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.	15
Cautionary Statement Concerning Forward-Looking Statements	15
Results of Operations for the Three Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021	15
Results of Operations for the Six Months Ended March 31, 2022 Compared to the Six Months Ended March 31, 2021	16
Liquidity and Capital Resources	17
Off-Balance Sheet Arrangements	17
Item 3. Quantitative and Qualitative Disclosures About Market Risk.	18
Item 4. Controls and Procedures.	18
Evaluation of Disclosure Controls and Procedures	18
Changes in Internal Control Over Financial Reporting	18

PART II — OTHER INFORMATION	19
Item 1. Legal Proceedings.	19
Item 1A. Risk Factors.	19
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	19
Item 3. Defaults Upon Senior Securities.	19
Item 4. Mine Safety Disclosures.	19
Item 5. Other Information.	19
Item 6. Exhibits.	20
SIGNATURES	21

Part I — Financial Information

Item 1. Financial Statements.

NOVACCESS GLOBAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2022			September 30, 2021
	(Unaudited)
ASSETS

CURRENT ASSETS
Cash	$	61,609		$	180,668
Employee Advances		-			380
Prepaid expenses		21,898			27,086

TOTAL ASSETS	$	83,507		$	208,134


LIABILITIES AND SHAREHOLDERS' DEFICIT

CURRENT LIABILITIES
Accounts payable	$	161,922		$	143,074
Other payable		66,894			66,894
Accrued expenses and interest on notes payable		105,783			356,683
Accrued payroll		11,268			10,712
Deferred Compensation		270,433			201,383
License Fees Payable		36,912			40,402
Derivative liability		2,400,203			2,553,979
Derivative liability warrants		597,997			372,643
Due to related party		86,073			82,922
Payable to TN3		200,000			-
Promissory notes payable net of debt discount and debt issuance costs of $188,247 and $395,027, respectively		561,753			104,973
Bridge Loans Payable - related parties		4,608			-
Convertible loan payable		12,000			12,000
Convertible promissory notes net of debt discount and debt issuance costs of $0 and $69,567, respectively		-			24,683

Total Current Liabilities		4,515,846			3,970,348

LONG TERM LIABILITIES
Convertible promissory notes		165,880			165,880

Total Long Term Liabilities		165,880			165,880

TOTAL LIABILITIES		4,681,726			4,136,228

SHAREHOLDERS' DEFICIT
Preferred stock 50,000,000 shares authorized, shares issued and outstanding designated as follows:
Preferred Stock Series B, $0.01 par value, 25,000 authorized 600 and 25,000 shares issued and outstanding, respectively		6			250
Common stock, no par value; 2,000,000,000 authorized common shares 17,523,673 and 14,404,030 shares issued and outstanding, respectively		42,921,963			41,882,535
Additional paid in capital		5,356,398			5,351,398
Paid in capital, common stock warrants		4,210,960			4,210,960
Paid in capital, preferred stock		4,747,108			5,088,324
Accumulated deficit		(61,834,654	)		(60,461,561	)

TOTAL SHAREHOLDERS' DEFICIT		(4,598,219	)		(3,928,094	)

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	83,507		$	208,134

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

NOVACCESS GLOBAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDED MARCH 31, 2022 AND 2021

(Unaudited)

	Three Months Ended						Six Months Ended
	March 31, 2022			March 31, 2021			March 31, 2022			March 31, 2021

OPERATING EXPENSES
Research and development expenses		45,516			8,446			87,915			8,446
Selling, general and administrative expenses		381,428			272,873			661,358			1,672,764

TOTAL OPERATING EXPENSES		426,944			281,319			749,273			1,681,210

LOSS FROM OPERATIONS BEFORE OTHER INCOME/(EXPENSES)		(426,944	)		(281,319	)		(749,273	)		(1,681,210	)

OTHER INCOME/(EXPENSES)
Gain (Loss) on change in derivative liability		(492,425	)		(382,539	)		(33,399	)		1,180,067
Extinguishment of derivatives		-			-			96,205			-
Extinguishment of debt		(54,813	)		-			(54,813	)		-
Interest expense		(255,603	)		(5,348	)		(631,813	)		(12,949	)

TOTAL OTHER INCOME/(EXPENSES)		(802,841	)		(387,887	)		(623,820	)		1,167,118

NET INCOME (LOSS)		(1,229,785	)		(669,206	)		(1,373,093	)		(514,092	)

BASIC INCOME (LOSS) PER SHARE	$	(0.08	)	$	(0.05	)	$	(0.09	)	$	(0.06	)

DILUTED INCOME (LOSS) PER SHARE	$	(0.08	)	$	(0.05	)	$	(0.09	)	$	(0.06	)

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC		15,379,289			12,455,164			14,914,920			9,099,121
DILUTED		15,379,289			12,455,164			14,914,920			9,099,121

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

NOVACCESS GLOBAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT

FOR THE SIX MONTHS ENDED MARCH 31, 2022 AND 2021

SIX MONTHS ENDED MARCH 31, 2021
																Stock Options/ Warrants Paid in
																		Paid in Capital, Preferred
													Additional Paid-in
	Preferred Stock, Class A				Preferred Stock, Class B				Common Stock				Additional Paid-in							Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Capital			Capital		Stock		Deficit			Total
Balance at September 30, 2020		-	$	-		25,000	$	250		1,603,492	$	33,369,424	$	11,710,398		$	4,210,960	$	5,088,324	$	(57,949,086	)	$	(3,569,730	)

Common stock issued for StemVax Acquisition - from stock payable		-		-		-		-		7,500,000		6,375,000		(6,375,000	)		-		-		-			-

Stock compensation cost		-		-		-		-		2,000,000		936,000		-			-		-		-			936,000

Common stock issued for Services		-		-		-		-		311,945		145,941		-			-		-		-			145,941

Common Stock Issued - Subscriptions		-		-		-		-		1,440,905		295,000		-			-		-		-			295,000

Net Income		-		-		-		-		-		-		-			-		-		(514,092	)		(514,092	)
Balance at March 31, 2021 (Unaudited)		-	$	-		25,000	$	250		12,856,342	$	41,121,365	$	5,335,398		$	4,210,960	$	5,088,324	$	(58,463,178	)	$	(2,706,881	)

SIX MONTHS ENDED MARCH 31, 2022
																	Stock Options/ Warrants Paid in
																			Paid in Capital, Preferred
															Additional Paid-in
	Preferred Stock, Class A				Preferred Stock, Class B						Common Stock				Additional Paid-in							Accumulated
	Shares		Amount		Shares			Amount			Shares		Amount		Capital		Capital		Stock			Deficit			Total
Balance at September 30, 2021		-	$	-		25,000.00		$	250			14,404,030	$	41,882,535	$	5,351,398	$	4,210,960	$	5,088,324		$	(60,461,561	)	$	(3,928,094	)

Preferred Stock Redemption		-		-		(24,400	)		(244	)		1,502,670		525,935		-		-		(341,216	)		-			184,475

Stock compensation cost		-		-		-			-			10,000		8,000		-		-		-			-			8,000

Common Stock issued for services		-		-		-			-			265,973		119,480		-		-		-			-			73,861

Common Stock issued , subscriptions		-		-		-			-			791,000		170,200		-		-		-			-			170,200

Common Stock issued as repayment of loans		-		-		-			-			250,000		104,813		-		-		-			-			50,000

Common Stock issued as commitment fee on promissory note payable		-		-		-			-			300,000		111,000		-		-		-			-			111,000

Common Stock Issuable, Subscriptions		-		-		-			-			-		-		5,000		-		-			-			5,000

Net Loss		-		-		-			-			-		-		-		-		-			(1,373,093	)		(1,373,093	)
Balance at March 31, 2022 (Unaudited)		-	$	-		600.00		$	6			17,523,673	$	42,921,963	$	5,356,398	$	4,210,960	$	4,747,108		$	(61,834,654	)	$	(4,598,219	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

NOVACCESS GLOBAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED MARCH 31, 2022 AND 2021

(Unaudited)

	For the Six Months Ended
	March 31, 2022			March 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(1,373,093	)	$	(514,092	)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities
Amortization of debt discount and debt issuance costs recorded as interest expense		479,689			-
(Gain)/Loss on change in derivative liability		33,399			(1,180,067	)
Extinguishment of derivatives		(96,205	)		-
Extinguishment of debt		54,813			-
Stock compensation expense		53,619			936,000
Stock issued and issuable for services		73,861			145,941
Stock issued as commitment fee on promissory note payable		79,043			-
Non-cash interest expense on bridge loan		546			-


Changes in Assets and Liabilities:
Employee advances		380			-
Prepaid expenses		5,188			-
Accounts payable		39,700			163,310
Other payable		-			1,590
License fees payable		(3,490	)		(10,000	)
Accrued expenses and interest on notes payable		144,100			32,999
Accrued payroll		556			23,290
Deferred Compensation		69,050			120,508

NET CASH USED IN OPERATING ACTIVITIES		(438,844	)		(280,521	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Stock subscriptions received		175,200			295,000
Due to related party		3,151			6,628
Proceeds from a note payable		213,000			-
Payments to TN3 for redemption of preferred stock		(50,000	)		-
Payments on convertible notes payable		(94,250	)		-
Proceeds from bridge loans payable - related parties		75,000			-
Payment on the bridge loans payable		(2,316	)
Proceeds from a related party loan		-			25,000
Payments on related party loan payable		-			(24,287	)


NET CASH PROVIDED BY FINANCING ACTIVITIES		319,785			302,341

NET INCREASE (DECREASE) IN CASH		(119,059	)		21,820

CASH, BEGINNING OF PERIOD		180,668			178

CASH, END OF PERIOD	$	61,609		$	21,998

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	71,245		$	1,386
Taxes paid	$	-		$	-

SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Accrued interest capitalized into convertible note	$	546		$	2,505
Shares issued for StemVax Acquisition – from stock payable	$	-		$	6,375,000
Cash payable to TN3 for preferred stock	$	200,000		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

1. ORGANIZATION AND LINE OF BUSINESS

Organization

NovAccess Global Inc. (“NovAccess,” the “Company”) is a Colorado corporation formerly known as Sun River Mining Inc. and XsunX, Inc. The Company was originally incorporated in Colorado on February 25, 1997. Effective September 24, 2003, the Company completed a plan of reorganization and name change to XsunX, Inc. In June 2020, the Company was acquired and changed its name to NovAccess Global Inc.

Line of Business

NovAccess Global Inc. is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We specialize in cutting-edge research related to utilizing a patient’s own immune system to attack the cancer. We are filing an Investigational New Drug Application (IND) and working closely with the Food and Drug Administration (FDA) to obtain approval for human clinical trials to determine safety and efficacy of our drug product for brain cancer patients. Once we have successfully completed the clinical trials and proven that the new therapy is safe and efficacious, we plan to commercialize the product. We also have expertise in successfully executing clinical trials, bringing products to market and increasing the market size of products through our advisory board. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecules development, gene therapy and other technical assays needed for protein and genetic analysis of cancer cells.

NovAccess operates as a research and development (R&D) company out of Ohio and California, and our executive management and scientific advisory board provide over 15 years of extensive experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates. We guide our performance by striving to deliver consistently on the following core objectives: (1) Accountability — taking responsibility for providing safe and effective options for patients; (2) Integrity — doing what is ethically right for the patient; (3) Excellence — doing your best and working hard; and (4) Teamwork — bringing together a strong working team to deliver the best products for brain tumor patients.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the six months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ended September 30, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended September 30, 2021.

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern.

The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders and lenders since its inception through the period ended March 31, 2022. Management believes the existing shareholders and the prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its business.

This summary of significant accounting policies of NovAccess is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary StemVax, LLC. All significant inter-company accounts and transactions between these entities have been eliminated in these condensed consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements. Significant estimates made in preparing these consolidated financial statements include the estimate of derivative liabilities, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.

Cash and Cash Equivalents

For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less.

Property and Equipment

Property and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives:

Leasehold improvements	Length of the lease
Computer software and equipment	3 Years
Furniture & fixtures	5 Years
Machinery & equipment	5 Years

The Company capitalizes property and equipment over $500. Property and equipment under $500 are expensed in the year purchased.

Stock-Based Compensation

Share-based Payment applies to transactions in which an entity exchanges its equity instruments for goods or services and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We are required to follow a fair value approach using an option-pricing model, such as the Binomial lattice valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option. This has not had a material impact on our results of operations.

Net Earnings (Loss) per Share Calculations

Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the period. Diluted net earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the effect of stock options and stock-based awards plus the assumed conversion of convertible debt (Notes 4 and 5). 

	For the three months ended						For the six months ended
	March 31,						March 31,
	2022			2021			2022			2021
Loss to common shareholders (Numerator)	$	(1,229,785	)	$	(669,206	)	$	(1,373,093	)	$	(514,092	)

Basic weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Diluted weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Diluted weighted average number of shares for the three and six months ended March 31, 2022 and March 31, 2021 is the same as basic weighted average number of shares because the Company had net losses for these respective periods.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Fair Value of Financial Instruments

Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2022, the balances reported for cash, prepaid expenses, accounts payable, accrued expenses approximate the fair value because of their short maturities.

We adopted Accounting Standards Codification (“ASC”) Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, an established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

●

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. The Company had no assets that are required to be valued on a recurring basis as of March 31, 2022 and September 30, 2021. The Company had liabilities that are required to be measured at fair value on a recurring basis as follows at March 31, 2022 and September 30, 2021:

	Total		(Level 1)		(Level 2)		(Level 3)

Assets:	$	-	$	-	$	-	$	-

Liabilities:

Derivative Liability at fair value as of September 30, 2021	$	2,553,979	$	-	$	-	$	2,553,979
Derivative Liability warrants at fair value as of September 30, 2021	$	372,643	$	-	$	-	$	372,643
Derivative Liability at fair value as of March 31, 2022	$	2,400,203	$	-	$	-	$	2,400,203
Derivative Liability warrants at fair value as of March 31, 2022	$	597,997	$	-	$	-	$	597,997

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

	Derivative Liability			Derivative Liability Warrants
Balance as of September 30, 2021		2,553,979			372,643
Extinguishment of derivatives		(96,205	)		-
Initial derivative liabilities		134,384			-
Net (Gain)/Loss on change in fair value of derivative liability		(191,955	)		225,354
Ending balance as of March 31, 2022	$	2,400,203		$	597,997

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Recent Accounting Pronouncements

In May 2021, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) 2021-04—Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options, to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU are effective for public and nonpublic entities for fiscal years beginning after December 15, 2021, and interim periods with fiscal years beginning after December 15, 2021. Early adoption is permitted, including adoption in an interim period. The Company has evaluated the impact of the adoption of ASU 2021-04, which had no effect on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

3. CAPITAL STOCK

At March 31, 2022, the Company’s authorized stock consisted of 2,000,000,000 shares of common stock, with no par value. Effective August 25, 2020, we filed articles of amendment to our articles of incorporation with the Colorado Secretary of State to effectuate a 1-for-1,000 reverse stock split of the Company’s outstanding shares of common stock.

The Company is also authorized to issue 50,000,000 shares of preferred stock with a par value of $0.01 per share. The rights, preferences and privileges of the holders of the preferred stock are determined by the Board of Directors prior to issuance of such shares.

Preferred Stock

As of March 31, 2022 the Company had 600 shares of issued and outstanding Series B Preferred Stock following the conversion of 5,000 shares of Series A Preferred Stock and redemption of 24,400 shares of Series B Preferred Stock. The Series A shares were originally issued in consideration for the contribution of services by Tom Djokovich, the former President and Chief Executive Officer, to the Company valued at fifty dollars, which the Board deemed full and fair consideration. Because of such issuance, Mr. Djokovich had the ability to influence and determine stockholder votes. On March 18, 2020, the Company, Mr. Djokovich, and TN3, LLC, a Wyoming limited liability company owned by Daniel G. Martin (“TN3”), entered into a Stock Purchase Agreement (the “Agreement”). Pursuant to the Agreement, Mr. Djokovich agreed to sell his 5,000 shares of Series A Preferred Stock to TN3 in a private sale for cash. The holder of the Series A Preferred Stock could cast votes equal to not less than 60% of the total outstanding voting power of the Company on all matters voted on by the shareholders of the Company. On September 4, 2020, the Company issued 25,000 shares of unregistered Series B Convertible Preferred stock, $0.01 par value per share to TN3 in exchange for the redemption of 5,000 shares of Series A preferred stock. On March 14, 2022 the Novaccess redeemed 24,400 shares of the Company’s Series B Convertible Preferred Stock held by TN3. Irvin Consulting LLC, a company owned by Dwain Irvin, the CEO of NovAccess, purchased remaining 600 shares (please refer to Note 12 for more details).

Each share of outstanding Series B Preferred Stock entitles the holder to cast 40,000 votes. Each share of Series B Preferred Stock is convertible at the option of the holder into 10,000 common shares. In the event of any voluntary or involuntary liquidation, dissolution, or winding-up of the Corporation, the holders of shares of Series B Preferred Stock shall be paid out based on an as converted basis. Dividend for Series B Preferred Stock shall be declared on an as converted basis.

Common Stock

Effective August 25, 2020, we filed articles of amendment to our articles of incorporation with the Colorado Secretary of State to effectuate a 1-for-1,000 reverse stock split of the Company’s outstanding shares of common stock.

Table of Contents

NOVACCESS GLOBAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

3. CAPITAL STOCK (Continued)

During the six months ended March 31, 2022, the Company issued 3,119,643 shares of common stock. 1,502,670 shares were issued to TN3 as part of the transaction to redeem 24,400 shares of Series B Preferred Stock, 265,973 shares were issued to various vendors for services provided; 791,000 shares were issued in relation to stock subscriptions; 300,000 shares were issued as a commitment fee on a promissory note payable; 250,000 shares were issued as repayment of bridge loans (please refer to Note 4 for more details); and 10,000 shares were issued to related parties (please refer to Note 12 for more details).

During the six months ended March 31, 2021, the Company issued 11,252,850 shares of common stock. For an expense of $145,941 based on the closing market value on grant date 311,945 shares were issued to various vendors for services provided; 1,440,905 shares were issued in relation to stock subscriptions for net proceeds of $295,000; and 9,500,000 shares were issued to related parties for services and expense at $936,000 based upon the closing market value on grant date.

4. CONVERTIBLE PROMISSORY NOTES

As of March 31, 2022, the outstanding convertible promissory notes are summarized as follows:

Convertible Promissory Notes	$	165,880
Less current portion		-
Total long-term liabilities	$	165,880

Maturities of long-term debt for the next four years are as follows:

Year Ending
September 30,
2023		165,880
	$	165,880

On November 20, 2014, the Company issued a 10% unsecured convertible promissory note (the “2014 Note”) for the principal sum of up to $400,000 plus accrued interest on any advanced principal funds. The 2014 Note matures eighteen months from each advance. The 2014 Note may be converted by the lender into shares of common stock of the Company at the lesser of $12.50 per share or (b) fifty percent (50%) of the lowest trade prices following issuance of the 2014 Note or (c) the lowest effective price per share granted to any person or entity. On November 20, 2014, the lender advanced $50,000 to the Company under the 2014 Note at inception. On various dates from February 18, 2015 through September 30, 2016, the lender advanced an additional $350,000 under the 2014 Note. During the period ended September 30, 2021, the Company and lender agreed to extend the maturity date for the outstanding balance to June 30, 2023. As of March 31, 2022, there remains an aggregate outstanding principal balance of $50,880.

On May 10, 2017, the Company issued a 10% unsecured convertible promissory note (the “2017 Note”) for the principal sum of up to $150,000 plus accrued interest on any advanced principal funds. The lender may pay additional consideration at the lender’s discretion. The Company received a tranche in the amount of $25,000 upon execution of the 2017 Note. On various dates, the Company received additional tranches in the aggregate sum of $90,000. The 2017 Note matured twelve months from each tranche. Within thirty (30) days prior to the maturity date, the lender may extend the maturity date to sixty (60) months. During the period ended September 30, 2021, the Company and lender agreed to extend the maturity date for the outstanding balance to June 30, 2023. The 2017 Note may be converted by the lender into shares of common stock of the Company at the lesser of $10 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity. As of March 31, 2022, the balance remaining on the May Note was $115,000.

On June 2, 2021, the Company issued a 12% unsecured convertible promissory note (the “June Note”) for the principal sum of $55,500 plus accrued interest. The June Note was to mature on June 2, 2022. The June Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion. On October 5, 2021 the Company paid the balance of this note to the lender including accrued interest and prepayment settlement fee of $17,520. The Company recorded amortization of debt discount of $36,493 and amortization of debt issuance costs of $1,458, both of which were recognized as interest expense during the six months ended March 31, 2022. The Company also recognized a gain of $59,915 on the extinguishment of this convertible note during the six months ended March 31, 2022. As of March 31, 2022, the balance of the June Note was $0.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

4. CONVERTIBLE PROMISSORY NOTES (Continued)

On July 6, 2021, the Company issued a 12% unsecured convertible promissory note (the “July Note”) for the principal sum of $38,750 plus accrued interest. The July Note was to mature on July 6, 2022. The July Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion. On December 30, 2021 the Company paid the balance of this note to the lender including accrued interest and prepayment settlement fee of $16,936. The Company recorded amortization of debt discount of $29,620 and amortization of debt issuance costs of $1,996, both of which were recognized as interest expense during the six months ended March 31, 2022. The Company also recognized a gain of $36,289 on the extinguishment of this convertible note during the six months ended March 31, 2022. As of March 31, 2022, the balance of the June Note was $0.

On August 20, 2021, the Company issued a 10% unsecured promissory note (the “August Note”) for the principal sum of $500,000 plus accrued interest. The August Note was to mature on February 20, 2022, unless extended for up to an additional six months. The August Note may be converted, only following an event of default, and therefore not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period. In February 2022 the Company extended the term of the August note for an additional six months. The extended maturity date is February 20, 2023. The Company recorded amortization of debt discount of $391,319 related to derivative portion of the August Note, amortization of debt issuance costs of $75,000, and $34,181 amortization of debt discount representing commitment fee all of which were recognized as interest expense during the six months ended March 31, 2022 in the consolidated statement of operations for the six months ended March 31, 2022. As of March 31, 2022, the balance of the August Note was $500,000.

On February 16, 2022, the Company issued a 10% unsecured promissory note (the “February note”) for the principal sum of $250,000 plus accrued interest. The February Note matures on August 15, 2022, unless extended for up to an additional six months. The February Note may be converted, only following an event of default, and therefore is not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period. The Company recorded amortization of debt discount of $32,849 related to derivative portion of the February Note and amortization of debt issuance costs of $9,250, and $19,654 amortization of debt discount representing commitment fee, all of which were recognized as interest expense during the three months ended March 31, 2022, in the consolidated statement of operations for the three months ended March 31, 2022. As of March 31, 2022, the balance of the August Note was $250,000, which is the total of initial debt discount of $134,384, initial debt issuance costs of $37,000 and initial debt discount representing a commitment fee of $78,616.

We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The notes have no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the notes under paragraph 815-15-25-4, whereby there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the notes in their entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations based upon the Binomial lattice model calculation.

The convertible notes issued and described in this Note 4 above, do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as a derivative liability to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

We record the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the notes.

At March 31, 2022, the fair value of the derivative liability was $2,400,203.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

4. CONVERTIBLE PROMISSORY NOTES (Continued)

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation of the derivatives are as follows:

Risk free interest rate		Between 0.73%and 2.28%
Stock volatility factor		Between 144.0% and 336.0%
Months to Maturity		0 - 5 years
Expected dividend yield		None

5. CONVERTIBLE LOAN PAYABLE

As of March 31, 2016, Company issued an unsecured Convertible Promissory Note (the “Note”) in the amount of $12,000 to a former Board member (the “Holder”) in exchange for retention as a director during the fiscal year ending September 30, 2014. The Note can be converted into shares of common stock by the Holder for $4.50 per share. The Note matured on October 1, 2015, and bore a one-time interest charge of $1,200 which was applied to the principal on October 1, 2014. So long as any shares issuable under a conversion are subject to transfer and sale restrictions imposed pursuant to SEC Rule 144 of the Rules promulgated under the Securities Act of 1933, the Company shall, upon written request by Holder, file Form S-8, if applicable, with the U.S. Securities and Exchange commission to register the issued.

6. WARRANTS

On August 20, 2021, for value received in connection with the issuance of the August Note (see note 4 for more details), the Company issued 1,000,000 warrants to the lender with an exercise price of $1.50 per share with a five-year exercise period.

On February 16, 2022, for value received in connection with the issuance of the February Note (see note 4 for more details), the Company issued 500,000 warrants to the lender with an exercise price of $1.50 per share with a five-year exercise period.

At March 31, 2022, and September 30, 2021, the fair value of the derivative liability warrants was $597,997 and $372,643, respectively.

For the purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation of the derivatives are as follows:

Risk free interest rate		2.42%
Stock volatility factor		Between 140% and 145%
Months to Maturity		5 years
Expected dividend yield		None

7. OPTIONS

On June 2, 2020, the Company issued 2,000,000 options to purchase common stock at an exercise price of $0.01 per share (adjusted for the August 2020 stock split). These options will be exercisable on a cashless basis for a period of ten years from August 25, 2020. The purpose of the options is to compensate our directors for serving on the board without compensation in fiscal 2019. It is difficult to assess the value of the options given the highly limited trading in our common stock, the fact that the options shares have not been and are not expected to be registered for resale and will be restricted, and the speculative nature of the Company’s future business plans. However, we estimated the value of the services provided by each of our directors during 2019 and believe that the value of the options to be issued to each of our resigning directors approximates that amount.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

7. OPTIONS (Continued)

At March 31, 2022, the weighted average remaining contractual life of options outstanding:

March 31, 2022

Weighted

Average

Remaining

Exercisable

Options

Contractual

Prices

Outstanding

Exercisable

Life (years)

0.01

2,000,000

8.41

8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities consisted of the following at March 31, 2022 and September 30, 2021:

	03/31/2022		9/30/2021
Trade accounts payable	$	161,922	$	143,074
Credit cards payable		66,894		66,894
Accrued liabilities and interest on notes payable		105,783		356,683
Accrued payroll		11,268		10,712
Deferred compensation		270,433		201,383
License fees payable		36,912		40,402
		653,212		819,148

9. BRIDGE LOANS PAYABLE

Related Parties

In December 2021, the Company’s CEO and CFO each advanced funds to the Company for operating expenses in the total amount of $50,000. The notes were payable on demand with a five business day written notice and bear interest at a rate of 10% per annum. The Company could prepay all or any part of the balance owed without penalty. In the event of the default, the notes were to bear additional interest at a rate of 12% per annum. On January 25, 2022 the Company issued 125,000 shares of its common stock in settlement of a bridge loan to the Company’s CFO and recognized a loss on extinguishment of debt in the amount of $17,313. Any potential gain would not have been recognized on extinguishment of this loan due to the nature of the relationship between the parties. The company recognized and paid interest expense in the amount of $237 to our CFO during the period ended March 31, 2022.

During the period ended March 31, 2022 the Company made payments to our CEO in the total amount of $20,938, of which $18,616 were used to purchase 600 shares of Serie B Preferred stock, and $2,316 were related to reimbursement of expenses. The company recognized and capitalized into the principle of the loan interest expense of $546. As of March 31, 2022, the balance on the bridge loan payable to our CEO was $4,068. No balance was outstanding on the notes payable to our CFO.

Service Provider

In December 2021, one of the Company’s service providers advanced funds to the Company for operating expenses in the total amount of $25,000. On February 14, 2022 the Company issued 125,000 shares of its common stock to the service provider in settlement of the note payable. The Company recognized a loss on extinguishment of debt in the amount of $37,500. During the period ended March 31, 2022 the Company recognized and paid interest expense of $226 in relation to this loan. No balance was outstanding on the note payable to our service provider as of March 31, 2022.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

10. DUE TO RELATED PARTY

During the periods prior to the period ended March 31, 2022, Innovest Global, Inc. (Innovest) advanced funds to the Company for operating expenses in the amount of $86,073. As of March 31, 2022, the amount has not been reimbursed to Innovest. Our former Chairman Daniel Martin was the CEO of Innovest when the funds were advanced. Imputed interest is calculated on an annual basis at the market rate and is estimated to equal $516 as of March 31, 2022.

11. COMMITMENTS AND CONTINGENCIES

There are no material pending legal proceedings to which we are a party to, nor are there any such proceedings known to be contemplated by governmental authorities. None of our directors, officers, or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

12. RELATED PARTY TRANSACTIONS

On September 4, 2020, the Company entered into a management services agreement (the “Agreement”) with TN3, LLC. Pursuant to the Agreement, TN3 was to provide NovAccess with office space in Chesterland, Ohio and management, administrative, marketing, bookkeeping and IT services for a fee of $30,000 a month. The initial term of the Agreement was three years, with subsequent one-year renewals. During the three months ended March 31, 2022, the Company entered into a transaction with TN3 to redeem its shares of the Company’s Series B Convertible preferred stock (please refer to more details below). This transaction terminated the Agreement, including satisfaction for all services provided and any amounts outstanding. As of March 31, 2022 there was zero balance reported as the outstanding payable amount in relation to the Agreement.

On October 4, 2021, the Company issued 10,000 shares of common stock to Neil J. Laird to compensate him for serving as our chief financial officer. The stock-based compensation expense in the amount of $8,000 was reported on the Company’s financial statements for the six months ended March 31, 2022.

On January 31, 2022, the Company entered into a preferred stock redemption agreement (the “redemption agreement”) with Daniel G. Martin, at the time our sole board member and chairman, TN3, LLC, a company owned by Mr. Martin, Dwain K. Morris-Irvin, our chief executive officer, and Irvin Consulting, LLC, a company owned by Dr. Irvin. TN3 owned 25,000 shares of our Series B convertible preferred stock. Pursuant to the redemption agreement, on March 14, 2022, NovAccess redeemed 24,400 of the preferred shares and Irvin Consulting purchased 600 of the preferred shares from TN3. In connection with the redemption, we issued to TN3 1,502,670 shares of unregistered common stock. To redeem the preferred shares, the Company is to pay TN3 a total of $250,000 over a period of ten months, with payment accelerated if the company raises significant capital. The company paid $50,000 to TN3 in relation to this transaction during the three months ended March 31, 2022. As of March 31, 2022 the balance owed to TN3 on this transaction is $200,000.

Upon completion of the redemption, Mr. Martin resigned from the NovAccess board of directors and was replaced by Dr. Irvin and John Cassarini. On March 18, 2022, the board of directors of NovAccess voted to expand the size of the company’s board to three members and appointed Jason M. Anderson to the board to fill the resulting vacancy.

Table of Contents

NOVACCESS GLOBAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED

MARCH 31, 2022 AND 2021

13. SUBSEQUENT EVENTS

Management has evaluated subsequent events as of May 13, 2022, the date the consolidated financial statements were available to be issued according to the requirements of ASC topic 855.

On May 5, 2022, NovAccess entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of $1.0 million (the “note”) to AJB pursuant to the SPA. The loan closed and was funded on May 9, 2022. NovAccess used $500,000 of the proceeds of the loan to repay AJB’s August 20, 2021 loan and will use the remaining loan proceeds for general working capital purposes.

The note has an original issuance discount of 10% of the principal and bears interest at 12% a year. The note is due on November 5, 2022, but may be extended for six months by NovAccess, at which time the rate will increase to 15%. NovAccess must repay the note with the proceeds of any loan or capital raise exceeding $5.0 million and may otherwise prepay the note at any time without penalty. Under the terms of the note, NovAccess may not sell a significant portion of its assets without the approval of AJB, may not issue additional debt that is not subordinate to AJB, must comply with the company’s reporting requirements under the Securities Exchange Act of 1934, and must maintain the listing of the company’s common stock on the OTC Market or other exchange, among other restrictions and requirements. NovAccess’ failure to make required payments under the note or to comply with any of these covenants, among other matters, would constitute an event of default. Upon an event of default under the SPA or note, the note will bear interest at 18%, AJB may immediately accelerate the note due date, AJB may convert the amount outstanding under the note into shares of NovAccess common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

NovAccess provided customary representations and covenants to AJB in the SPA. NovAccess’ breach of any representation or failure to comply with the covenants would constitute an event of default. Also pursuant to the SPA, NovAccess paid AJB a commitment fee of 875,000 unregistered shares of the company’s common stock (the “commitment fee shares”). If, after May 5, 2023 and before May 5, 2025, AJB is unable to sell the commitment fee shares for $700,000, then AJB may require NovAccess to issue additional shares or pay cash in the amount of the shortfall. However, if NovAccess pays the note off before November 5, 2022, then the company may redeem 437,500 of the commitment shares for one dollar. Pursuant to the SPA, NovAccess also issued to AJB a common stock purchase warrant (the “warrant”) to purchase 1.0 million shares of the company’s common stock for $0.01 a share. The warrant expires on May 5, 2027. NovAccess also entered into a security agreement with AJB (the “security agreement”) pursuant to which NovAccess granted to AJB a security interest in all of the company’s assets, including the equity of StemVax, LLC, securing NovAccess’ obligations under the SPA, note and warrant. In addition, NovAccess entered into a registration rights agreement with AJB (the “registration agreement”) pursuant to which NovAccess agreed to file with the Securities and Exchange Commission a Form S-1 by August 3, 2022 to register for resale the commitment fee shares and the shares issuable upon exercise of the warrant.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Cautionary Statement Concerning Forward-Looking Statements

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q. In addition to historical consolidated financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results could differ materially from those anticipated by these forward-looking statements as a result of many factors, including those discussed under Item 1A. Risk Factors of our Form 10-K for the fiscal year ended September 30, 2021.

We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date of this report. Readers should carefully review the factors described in other documents that NovAccess files from time to time with the SEC.

Results of Operations for the Three Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021

Revenue and Cost of Sales:

The Company generated no revenue or cost of goods sold in the second quarters of fiscal years ended March 31, 2022 and 2021.

Research and development expenses

In the second quarter of 2022 the Company incurred $45,516 in research and development expenses related to activities performed by Dr. Christopher Wheeler and Dr. Dwain K. Morris-Irvin related to preparing the application to obtain FDA approval to start human clinical trials for StemVax Glioblast (SVX-GB) compared to $8,446 incurred in the second quarter of 2021.

Selling, General and Administrative Expenses:

Selling, general and administrative (SG&A) expenses increased by $108,555 during the second quarter 2022 to $381,428 as compared to $272,873 for the second quarter of 2021. The increase in SG&A expenses was related primarily to increase of $55,541 in legal expenses related to the Series B Convertible Preferred Stock redemption transaction, increase of $48,018 in accounting and CFO services fees, recognition of $25,000 in insurance expense and $45,619 in stock compensation for a service provider, partially offset by $38,643 decrease in payroll related expenses due to the Company having a lower head count in the second quarter of 2022 compared to the second quarter of 2021, as well as a decrease of $25,600 in other professional fees and outside services due to termination of management services Agreement with TN3 and timing of investors relations services.

Other Income/(Expenses):

Other net expense increased by $414,954 to $802,841 for the second quarter of fiscal 2022 from $387,887 for the second quarter of fiscal 2021. The increase in net total other expense was primarily due to recognition of a $109,886 higher loss on net change in fair market value of the derivative instruments in the second quarter of 2022 compared to the loss recognized in the second quarter of 2021, as well as recognition of $202,053 amortization of debt discount, commitment fees on notes payable and debt issuance costs on loans entered to in fiscal 2022.

Net Loss:

For the second quarter of fiscal 2022, our net loss was $1,229,785 as compared to a net loss of $669,206 for the second quarter of fiscal 2021. The increase in net loss of $560,579 was due to an increase in net other expenses associated with the net change in derivative instruments estimated each period and increase in interest expense and other financing costs, as well as an increase in SG&A expenses and higher research and development expenses recognized in fiscal 2022.

Table of Contents

Results of Operations for the Six Months Ended March 31, 2022 Compared to the Six Months Ended March 31, 2021

Revenue and Cost of Sales:

The Company generated no revenue or cost of goods sold for the six months ended March 31, 2022 and March 31, 2021.

Research and development expenses

In the six months ended March 31, 2022 the Company incurred $87,915 in research and development expenses related to activities performed by Dr. Christopher Wheeler and Dr. Dwain K. Morris-Irvin related to preparing the application to obtain FDA approval to start human clinical trials for StemVax Glioblast (SVX-GB) compared to $8,446 recognized in the six months ended March 31, 2021.

Selling, General and Administrative Expenses:

Selling, general and administrative (SG&A) expenses decreased by $1,011,406 during the six months ended March, 31 2022 to $661,358 as compared to $1,672,764 for the six months ended March 31, 2021. The decrease in SG&A expenses was related primarily to the Company recognizing $846,000 in stock compensation expense in connection with the issuance of stock to our chief executive officer in fiscal 2021, as well as a decrease of $36,381 in other stock compensation expense. Payroll expenses also decreased by $117,904 in fiscal 2022 due to a $50,000 bonus accrual for our CEO in fiscal 2021, outsourcing CFO services and allocating a portion of our CEO compensation to research and development expenses in fiscal 2022. The decrease in payroll and stock compensation expenses are partially offset by increases of $61,117 in professional fees and outside services due to change in providers and timing of investors relations services.

Other Income/(Expenses):

Net other income decreased by $1,790,938 from other income of $1,167,118 for the six months ended March 31, 2021 to other expenses of $623,820 for the six months ended March 31, 2022. The decrease in net total other income was primarily due to recognition of a $1,213,446 lower gain on net change in fair market value of the derivative instruments in the six months ended March 31, 2022 compared to the gain recognized in the six months ended March 31, 2021, as well as recognition of $526,348 amortization of debt discount, commitment fees on notes payable, and debt issuance costs, partially offset by recognition of $96,205 gain on extinguishment of derivative liability and loss of $54,813 on extinguishment of bridge loans.

Net Loss:

For the six months ended March 31, 2022, our net loss was $1,373,093 as compared to a net loss of $514,092 for the six months ended March 31, 2021. The increase in net loss of $859,001 was due to a decrease in net other income associated with the net change in derivative instruments estimated each period and increase in interest expense and other financing costs partially offset by a decrease in SG&A expenses in 2022.

Table of Contents

Liquidity and Capital Resources

We had a working capital deficit as of March 31, 2022 of $4,432,339, compared to a working capital deficit of $3,762,214 as of September 30, 2021. The increase of $670,125 in working capital deficit was primarily the result of an increase in the balance of promissory notes payable and payable to TN3 for the Series B Preferred Stock redemption.

For the six months ended March 31, 2022, our cash flow used in operating activities was $438,844, compared to cash flow used in operating activities of $280,521 for the first half of 2021. The net increase of $158,323 in cash flow used in operating activities was primarily due to lower stock compensation expense, higher net loss and changes in assets and liabilities, partially offset by lower gain on change in derivative liabilities.

There was no cash flow provided by/(used in) investing activities for the six months ended March 31, 2022 or 2021.

Cash flow provided by financing activities was $319,785 for the six months ended March 31, 2022, compared to cash provided by financing activities of $302,341 during the first half of 2021. The increase in cash flow provided by financing activities was primarily the result of the mix of funds raised by selling equity and debt instruments.

The Company will need to raise additional funds to finance its ongoing operations, complete its Investigational New Drug (IND) application to the FDA and to make payments under its loan agreements. We expect this will require approximately $3.0 million through December 31, 2022. We plan to raise this capital through the issuance of additional common stock as well as obtaining additional debt as needed.

Off-Balance Sheet Arrangements

We do not have any relationships with unconsolidated entities or financial partnerships such as entities often referred to as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance-sheet arrangements or for other contractually narrow or limited purposes. As a result, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Because NovAccess is a “smaller reporting company” as defined by the Securities and Exchange Commission (the “SEC”) we are not required to provide quantitative and qualitative disclosures about market risk.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management team, with the participation of our chief executive officer, Dwain K. Morris-Irvin, and chief financial officer, Neil J. Laird, evaluated the effectiveness of the design and operation of NovAccess’ disclosure controls and procedures (as defined under the Securities Exchange Act) as of March 31, 2022. Based upon this evaluation, Messrs. Morris-Irvin and Laird concluded that the Company’s disclosure controls and procedures were effective as of March 31.

Changes in Internal Control Over Financial Reporting

Our senior management team is responsible for establishing and maintaining adequate internal control over financial reporting, defined under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers, or persons performing similar functions, and effected by our board, senior management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with United States generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. We continue to review our internal control over financial reporting and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our systems evolve with our business.

During the quarter the Company implemented enhanced review procedures for the accounting of certain derivatives and other income. This included engaging a third party to review the assumptions and calculation. There were no other changes in our internal control over financial reporting identified in connection with the evaluation required by the Securities Exchange Act that occurred during our first fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

Part II — Other Information

Item 1. Legal Proceedings.

We are not involved in any legal proceedings.

Item 1A. Risk Factors.

Please refer to the risk factors listed under Item 1A. Risk Factors of our Form 10-K for the fiscal year ended September 30, 2021 for information relating to certain risk factors applicable to NovAccess.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the quarter end of March 31, 2022, we issued 1,069,306 unregistered shares of our common stock for capital raising and compensatory purposes as described in more detail below.

During the quarter end of March 31, 2022, we offered unregistered shares of our common stock in a private placement to accredited investors to fund our working capital needs. During the quarter we sold to ten investors 840,000 shares for an aggregate amount of $170,000. Neil J. Laird, the company’s chief financial officer, and Letzhangout, LLC, a company that provides accounting consulting services to NovAccess (“Letzhangout”), each purchased 250,000 shares in the private placement for $0.20 a share (a portion of which was paid by the cancellation of loans made to the company in December 2021). The issuance of shares in the private placement was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506(a) under the Securities Act.

On March 31, 2022, we issued 108,750 of our unregistered shares to Letzhangout, LLC for accounting services provided to NovAccess. On February 14, 2022, we issued 85,000 shares to Letzhangout for accounting services. We recognized stock compensation expense in the amount of $45,619 in relation to stock issuances to this service provider. On February 23, 2022, we issued 35,556 shares of our shares to Satya Chillara, an employee of Darrow Associates, for investor relations services provided to NovAccess. The issuances of shares to our service providers were exempt from registration under Section 4(a)(2) of the Securities Act.

Item 3. Defaults Upon Senior Securities.

During the quarter ended March 31, 2022, NovAccess was not in material default with respect to any its material indebtedness.

Item 4. Mine Safety Disclosures.

We are not engaged in mining operations.

Item 5. Other Information.

We have disclosed on Form 8-K all reportable events that occurred in the quarter ended March 31, 2022.

Table of Contents

Item 6. Exhibits.

Exhibit		Description
31.1		Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Dwain Morris-Irvin
31.2		Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Neil J. Laird
32.1		Certification Pursuant to Section 906 of the Sarbanes-Oxley Act
101		The following materials from the NovAccess Global Inc. Quarterly Report on Form 10-Q for the period ended March 31, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at March 31, 2022 and September 30, 2021, (ii) the Condensed Consolidated Statements of Operations for the Three and Six Months Ended March 31, 2022 and March 31, 2021, (iii) the Condensed Consolidated Statements of Shareholders’ Deficit for the Six Months Ended March 31, 2022 and 2021, (iv) the Condensed Consolidated Statements of Cash Flows for the Six Months Ended March 31, 2022 and March 31, 2021, and (v) Related Notes to the Condensed Consolidated Financial Statements.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NovAccess Global Inc.

Date: May 13, 2022	/s/ Dwain K. Morris-Irvin
	Dwain K. Morris-Irvin, Chief Executive Officer
	(Principal Executive Officer)

Date: May 13, 2022	/s/ Neil J. Laird
	Neil J. Laird, Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-31.1 2 ex_372769.htm EXHIBIT 31.1 ex_372769.htm

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
17 CFR SECTION 240.13a-14(a)

I, Dwain Morris-Irvin, certify that:

1. I have reviewed this quarterly report on Form 10-Q of NovAccess Global Inc. for the period ending March 31, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2022

/s/ Dwain Morris-Irvin
Dwain Morris-Irvin, Chief Executive Officer

EX-31.2 3 ex_372770.htm EXHIBIT 31.2 ex_372770.htm

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
17 CFR SECTION 240.13a-14(a)

I, Neil J. Laird, certify that:

1. I have reviewed this quarterly report on Form 10-Q of NovAccess Global Inc. for the period ending March 31, 2022;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2022

/s/ Neil J. Laird
Neil J. Laird, Chief Financial Officer

EX-32.1 4 ex_372771.htm EXHIBIT 32.1 ex_372771.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report of NovAccess Global Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2022 (the “Report”) with the Securities and Exchange Commission, I, Dwain Morris-Irvin, Chief Executive Officer of the Company, and I, Neil J. Laird, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and the results of operations of the Company for such period.

Dated: May 13, 2022

/s/ Dwain Morris-Irvin
Dwain Morris-Irvin, Chief Executive Officer

/s/ Neil J. Laird
Neil J. Laird, Chief Financial Officer and Treasurer

EX-101.SCH 5 xsnx-20220331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - ORGANIZATION AND LINE OF BUSINESS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - CAPITAL STOCK link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - CONVERTIBLE PROMISSORY NOTES link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - CONVERTIBLE LOAN PAYABLE link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - WARRANTS link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - OPTIONS link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - BRIDGE LOANS PAYABLE - RELATED PARTIES link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - DUE TO RELATED PARTY link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - WARRANTS (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - OPTIONS (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - CAPITAL STOCK (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Debt link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Maturities of Long-term Debt link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - CONVERTIBLE LOAN PAYABLE (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - WARRANTS (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - WARRANTS (Details) - Fair Value Measurement Inputs and Valuation Techniques link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - OPTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - OPTIONS (Details) - Share-based Payment Arrangement, Option, Exercise Price Range link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - DUE TO RELATED PARTY (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 xsnx-20220331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 xsnx-20220331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 xsnx-20220331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Statement of Financial Position [Abstract] TOTAL ASSETS Accounts payable Accrued expenses and interest on notes payable Deferred Compensation Convertible loan payable Total Current Liabilities Convertible promissory notes Total Long Term Liabilities TOTAL LIABILITIES Preferred Stock Series B, $0.01 par value, 25,000 authorized 25,000 and 25,000 shares issued and outstanding, respectively Class of Stock [Axis] Common stock, no par value; 2,000,000,000 authorized common shares 17,523,673 and 14,404,030 shares issued and outstanding, respectively TOTAL SHAREHOLDERS' DEFICIT Balance Balance TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT Income Statement [Abstract] TOTAL OPERATING EXPENSES LOSS FROM OPERATIONS BEFORE OTHER INCOME/(EXPENSES) TOTAL OTHER INCOME/(EXPENSES) NET INCOME (LOSS) Net income (loss) Net Loss BASIC INCOME (LOSS) PER SHARE (in Dollars per share) DILUTED INCOME (LOSS) PER SHARE (in Dollars per share) BASIC (in Shares) Basic weighted average number of common shares outstanding (Denominator) Statement of Stockholders' Equity [Abstract] Balance (in Shares) Balance (in Shares) Equity Components [Axis] Statement of Cash Flows [Abstract] NET CASH USED IN OPERATING ACTIVITIES NET CASH PROVIDED BY FINANCING ACTIVITIES NET INCREASE (DECREASE) IN CASH CASH, BEGINNING OF PERIOD CASH, END OF PERIOD Accrued interest capitalized into convertible note Accounting Policies [Abstract] Property, Plant and Equipment [Abstract] Long-Lived Tangible Asset [Axis] Schedule of Earnings Per Share, Basic and Diluted [Abstract] Loss to common shareholders (Numerator) (in Dollars) Diluted weighted average number of common shares outstanding (Denominator) DILUTED (in Shares) Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract] Balance Balance Derivative Instrument [Axis] Stockholders' Equity Note [Abstract] Debt Disclosure [Abstract] Schedule of Debt [Abstract] Convertible Promissory Notes $ Total long-term liabilities Schedule of Maturities of Long-term Debt [Abstract] Debt Instrument [Axis] Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Abstract] Measurement Input Type [Axis] Statistical Measurement [Axis] Disclosure Text Block Supplement [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Abstract] Share-Based Payment Arrangement [Abstract] Share-based Payment Arrangement, Option, Exercise Price Range [Abstract] Payables and Accruals [Abstract] Schedule of Accounts Payable and Accrued Liabilities [Abstract] Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract] Commitments and Contingencies Disclosure [Abstract] Related Party Transactions [Abstract] Subsequent Events [Abstract] Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Central Index Key ASSETS CURRENT ASSETS Cash Employee Advances Prepaid expenses LIABILITIES AND SHAREHOLDERS' DEFICIT CURRENT LIABILITIES Other payable Accrued payroll License Fees Payable License fees payable Derivative liability Derivative Liability, Current Derivative liability warrants Derivative Liability warrants at fair value Embedded Derivative, Fair Value of Embedded Derivative Liability Due to related party Payable to TN3 Promissory notes payable net of debt discount and debt issuance costs of $188,247 and $395,027, respectively Promissory notes payable, debt discount and debt issuance costs (in Dollars) Bridge Loans Payable - related parties Convertible promissory notes net of debt discount and debt issuance costs of $0 and $69,567, respectively Convertible promissory notes, debt discount and debt issuance costs (in Dollars) LONG TERM LIABILITIES SHAREHOLDERS' DEFICIT Preferred stock 50,000,000 shares authorized, shares issued and outstanding designated as follows: Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, par (in Dollars per share) Preferred Stock, Par or Stated Value Per Share (in Dollars per share) Preferred stock, shares authorized Preferred Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common stock, shares outstanding Common stock, no par value (in Dollars per share) Additional paid in capital Paid in capital, common stock warrants Paid in capital, preferred stock Accumulated deficit OPERATING EXPENSES Research and development expenses Selling, general and administrative expenses OTHER INCOME/(EXPENSES) Gain (Loss) on change in derivative liability Extinguishment of derivatives Extinguishment of derivatives Extinguishment of debt Extinguishment of debt Gain (Loss) on Extinguishment of Debt WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING Common Stock issued for StemVax acquisition - from stock payable Shares issued for StemVax Acquisition – from stock payable Common Stock issued for StemVax acquisition - from stock payable (in Shares) Stock compensation cost Stock compensation cost (in Shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Common Stock issued for services Stock Issued During Period, Value, Issued for Services (in Dollars) Common Stock issued for services (in Shares) Stock Issued During Period, Shares, Issued for Services Common Stock issued , subscriptions Common Stock issued , subscriptions (in Shares) Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues (in Shares) Preferred Stock Redemption Preferred Stock Redemption (in Shares) Conversion of Stock, Shares Issued Common Stock issued as repayment of loans Common Stock issued as repayment of loans (in Shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Common Stock issued as commitment fee on promissory note payable Common Stock issued as commitment fee on promissory note payable (in Shares) Stock Issued During Period, Shares, Other CASH FLOWS FROM OPERATING ACTIVITIES: Adjustment to reconcile net loss to net cash provided by (used in) operating activities Amortization of debt discount and debt issuance costs recorded as interest expense Stock compensation expense Stock issued and issuable for services Stock issued as commitment fee on promissory note payable Non-cash interest expense on bridge loan Interest Costs Capitalized Changes in Assets and Liabilities: Accounts payable Other payable License fees payable Accrued expenses and interest on notes payable Accrued payroll Deferred Compensation CASH FLOWS FROM FINANCING ACTIVITIES: Stock subscriptions received Proceeds from Issuance of Common Stock (in Dollars) Due to related party Proceeds from a note payable Payments on convertible notes payable Proceeds from Convertible Debt Proceeds from bridge loans payable - related parties Proceeds from a related party loan Proceeds from Related Party Debt SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Interest paid Taxes paid SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS Cash payable to TN3 for preferred stock Interest expense (Gain)/Loss on change in derivative liability Employee advances EX-101.PRE 9 xsnx-20220331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Mar. 31, 2022	May 13, 2022
Document Information Line Items
Entity Registrant Name	NovAccess Global Inc.
Trading Symbol	N/A
Document Type	10-Q
Current Fiscal Year End Date	--09-30
Entity Common Stock, Shares Outstanding		18,398,673
Amendment Flag	false
Entity Central Index Key	0001039466
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-29621
Entity Incorporation, State or Country Code	CO
Entity Tax Identification Number	84-1384159
Entity Address, Address Line One	8584 E. Washington Street #127
Entity Address, City or Town	Chagrin Falls
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44023
City Area Code	213
Local Phone Number	642-9268
Title of 12(b) Security	N/A
Security Exchange Name	NONE
Entity Interactive Data Current	Yes

XML 11 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Sep. 30, 2021
CURRENT ASSETS
Cash	$ 61,609	$ 180,668
Employee Advances	0	380
Prepaid expenses	21,898	27,086
TOTAL ASSETS	83,507	208,134
CURRENT LIABILITIES
Accounts payable	161,922	143,074
Other payable	66,894	66,894
Accrued expenses and interest on notes payable	105,783	356,683
Accrued payroll	11,268	10,712
Deferred Compensation	270,433	201,383
License Fees Payable	36,912	40,402
Derivative liability	2,400,203	2,553,979
Derivative liability warrants	597,997	372,643
Due to related party	86,073	82,922
Payable to TN3	200,000	0
Promissory notes payable net of debt discount and debt issuance costs of $188,247 and $395,027, respectively	561,753	104,973
Bridge Loans Payable - related parties	4,608	0
Convertible loan payable	12,000	12,000
Convertible promissory notes net of debt discount and debt issuance costs of $0 and $69,567, respectively	0	24,683
Total Current Liabilities	4,515,846	3,970,348
LONG TERM LIABILITIES
Convertible promissory notes	165,880	165,880
Total Long Term Liabilities	165,880	165,880
TOTAL LIABILITIES	4,681,726	4,136,228
Preferred stock 50,000,000 shares authorized, shares issued and outstanding designated as follows:
Preferred Stock Series B, $0.01 par value, 25,000 authorized 25,000 and 25,000 shares issued and outstanding, respectively	6	250
Common stock, no par value; 2,000,000,000 authorized common shares 17,523,673 and 14,404,030 shares issued and outstanding, respectively	42,921,963	41,882,535
Additional paid in capital	5,356,398	5,351,398
Paid in capital, common stock warrants	4,210,960	4,210,960
Paid in capital, preferred stock	4,747,108	5,088,324
Accumulated deficit	(61,834,654)	(60,461,561)
TOTAL SHAREHOLDERS' DEFICIT	(4,598,219)	(3,928,094)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 83,507	$ 208,134

XML 12 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)	Mar. 31, 2022	Sep. 30, 2021
Promissory notes payable, debt discount and debt issuance costs (in Dollars)	$ 188,247	$ 395,027
Convertible promissory notes, debt discount and debt issuance costs (in Dollars)	$ 0	$ 69,567
Preferred stock, shares issued	25,000	25,000
Preferred stock, par (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	50,000,000
Common stock, shares authorized	2,000,000,000	2,000,000,000
Common stock, shares issued	17,523,673	14,404,030
Common stock, shares outstanding	17,523,673	14,404,030
Common stock, no par value (in Dollars per share)	$ 0	$ 0
Series B Preferred Stock [Member]
Preferred stock, shares issued	600
Preferred stock, shares authorized	25,000	25,000

XML 13 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
OPERATING EXPENSES
Research and development expenses	$ 45,516	$ 8,446	$ 87,915	$ 8,446
Selling, general and administrative expenses	381,428	272,873	661,358	1,672,764
TOTAL OPERATING EXPENSES	426,944	281,319	749,273	1,681,210
LOSS FROM OPERATIONS BEFORE OTHER INCOME/(EXPENSES)	(426,944)	(281,319)	(749,273)	(1,681,210)
OTHER INCOME/(EXPENSES)
Gain (Loss) on change in derivative liability	(492,425)	(382,539)	(33,399)	1,180,067
Extinguishment of derivatives	0	0	96,205	0
Extinguishment of debt	(54,813)	0	(54,813)	0
Interest expense	(255,603)	(5,348)	(631,813)	(12,949)
TOTAL OTHER INCOME/(EXPENSES)	(802,841)	(387,887)	(623,820)	1,167,118
NET INCOME (LOSS)	$ (1,229,785)	$ (669,206)	$ (1,373,093)	$ (514,092)
BASIC INCOME (LOSS) PER SHARE (in Dollars per share)	$ (0.08)	$ (0.05)	$ (0.09)	$ (0.06)
DILUTED INCOME (LOSS) PER SHARE (in Dollars per share)	$ (0.08)	$ (0.05)	$ (0.09)	$ (0.06)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC (in Shares)	15,379,289	12,455,164	14,914,920	9,099,121
DILUTED (in Shares)	15,379,289	12,455,164	14,914,920	9,099,121

XML 14 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Series B Preferred Stock [Member] Preferred Stock [Member]	Series B Preferred Stock [Member]	Common Stock Issuable [Member] Additional Paid-in Capital [Member]	Common Stock Issuable [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid in Capital Stock Options / Warrants [Member]	Retained Earnings [Member]	Additional Paid in Capital Preferred Stock [Member]	Total
Balance at Sep. 30, 2020	$ 250				$ 33,369,424	$ 11,710,398	$ 4,210,960	$ 5,088,324	$ (57,949,086)	$ (3,569,730)
Balance (in Shares) at Sep. 30, 2020	25,000				1,603,492
Common Stock issued for StemVax acquisition - from stock payable					$ 6,375,000	(6,375,000)				6,375,000
Common Stock issued for StemVax acquisition - from stock payable (in Shares)					7,500,000
Stock compensation cost					$ 936,000					$ 936,000
Stock compensation cost (in Shares)					2,000,000					9,500,000
Common Stock issued for services					$ 145,941					$ 145,941
Common Stock issued for services (in Shares)					311,945					311,945
Common Stock issued , subscriptions					$ 295,000					$ 295,000
Common Stock issued , subscriptions (in Shares)					1,440,905					1,440,905
Common Stock issued as commitment fee on promissory note payable (in Shares)										11,252,850
Net income (loss)									(514,092)	$ (514,092)
Balance at Mar. 31, 2021	$ 250				$ 41,121,365	5,335,398	4,210,960	5,088,324	(58,463,178)	(2,706,881)
Balance (in Shares) at Mar. 31, 2021	25,000				12,856,342
Balance at Sep. 30, 2021	$ 250				$ 41,882,535	5,351,398	4,210,960	5,088,324	(60,461,561)	(3,928,094)
Balance (in Shares) at Sep. 30, 2021	25,000				14,404,030
Preferred Stock Redemption	$ (244)				$ 525,935			(341,216)		$ 184,475
Preferred Stock Redemption (in Shares)	(24,400)				1,502,670					1,502,670
Common Stock issued for StemVax acquisition - from stock payable										$ 0
Stock compensation cost					$ 8,000					$ 8,000
Stock compensation cost (in Shares)					10,000					10,000
Common Stock issued for services					$ 119,480					$ 73,861
Common Stock issued for services (in Shares)					265,973					265,973
Common Stock issued , subscriptions			$ 5,000	$ 5,000	$ 170,200					$ 170,200
Common Stock issued , subscriptions (in Shares)		600			791,000					791,000
Common Stock issued as repayment of loans					$ 104,813					$ 50,000
Common Stock issued as repayment of loans (in Shares)					250,000					250,000
Common Stock issued as commitment fee on promissory note payable					$ 111,000					$ 111,000
Common Stock issued as commitment fee on promissory note payable (in Shares)		24,400			300,000					3,119,643
Net income (loss)									(1,373,093)	$ (1,373,093)
Balance at Mar. 31, 2022	$ 6				$ 42,921,963	$ 5,356,398	$ 4,210,960	$ 4,747,108	$ (61,834,654)	$ (4,598,219)
Balance (in Shares) at Mar. 31, 2022	600				17,523,673

XML 15 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (1,373,093)	$ (514,092)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities
Amortization of debt discount and debt issuance costs recorded as interest expense	479,689	0
(Gain)/Loss on change in derivative liability	33,399	(1,180,067)
Extinguishment of derivatives	(96,205)	0
Extinguishment of debt	54,813	0
Stock compensation expense	53,619	936,000
Stock issued and issuable for services	73,861	145,941
Stock issued as commitment fee on promissory note payable	79,043	0
Non-cash interest expense on bridge loan	546
Changes in Assets and Liabilities:
Employee advances	380	0
Prepaid expenses	5,188	0
Accounts payable	39,700	163,310
Other payable	0	1,590
License fees payable	(3,490)	(10,000)
Accrued expenses and interest on notes payable	144,100	32,999
Accrued payroll	556	23,290
Deferred Compensation	69,050	120,508
NET CASH USED IN OPERATING ACTIVITIES	(438,844)	(280,521)
CASH FLOWS FROM FINANCING ACTIVITIES:
Stock subscriptions received	175,200	295,000
Due to related party	3,151	6,628
Proceeds from a note payable	213,000	0
Payments to TN3 for redemption of preferred stock	(50,000)	0
Payments on convertible notes payable	(94,250)	0
Proceeds from bridge loans payable - related parties	75,000	0
Payment on the bridge loans payable	(2,316)
Proceeds from a related party loan	0	25,000
Payments on related party loan payable	0	(24,287)
NET CASH PROVIDED BY FINANCING ACTIVITIES	319,785	302,341
NET INCREASE (DECREASE) IN CASH	(119,059)	21,820
CASH, BEGINNING OF PERIOD	180,668	178
CASH, END OF PERIOD	61,609	21,998
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	71,245	1,386
Taxes paid	0	0
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Accrued interest capitalized into convertible note	546	2,505
Shares issued for StemVax Acquisition – from stock payable	0	6,375,000
Cash payable to TN3 for preferred stock	$ 200,000	$ 0

XML 16 R7.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND LINE OF BUSINESS

6 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1. ORGANIZATION AND LINE OF BUSINESS

Organization

Line of Business

Basis of Presentation

Going Concern

XML 17 R8.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less.

Property and Equipment

Property and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives:

Leasehold improvements	Length of the lease
Computer software and equipment	3 Years
Furniture & fixtures	5 Years
Machinery & equipment	5 Years

The Company capitalizes property and equipment over $500. Property and equipment under $500 are expensed in the year purchased.

Stock-Based Compensation

Net Earnings (Loss) per Share Calculations

	For the three months ended						For the six months ended
	March 31,						March 31,
	2022			2021			2022			2021
Loss to common shareholders (Numerator)	$	(1,229,785	)	$	(669,206	)	$	(1,373,093	)	$	(514,092	)

Basic weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Diluted weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Fair Value of Financial Instruments

●

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

●

	Total		(Level 1)		(Level 2)		(Level 3)

Assets:	$	-	$	-	$	-	$	-

Liabilities:

Derivative Liability at fair value as of September 30, 2021	$	2,553,979	$	-	$	-	$	2,553,979
Derivative Liability warrants at fair value as of September 30, 2021	$	372,643	$	-	$	-	$	372,643
Derivative Liability at fair value as of March 31, 2022	$	2,400,203	$	-	$	-	$	2,400,203
Derivative Liability warrants at fair value as of March 31, 2022	$	597,997	$	-	$	-	$	597,997

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

	Derivative Liability			Derivative Liability Warrants
Balance as of September 30, 2021		2,553,979			372,643
Extinguishment of derivatives		(96,205	)		-
Initial derivative liabilities		134,384			-
Net (Gain)/Loss on change in fair value of derivative liability		(191,955	)		225,354
Ending balance as of March 31, 2022	$	2,400,203		$	597,997

Recent Accounting Pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

XML 18 R9.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK

6 Months Ended

Mar. 31, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

3. CAPITAL STOCK

Preferred Stock

Common Stock

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

XML 19 R10.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES

6 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

4. CONVERTIBLE PROMISSORY NOTES

As of March 31, 2022, the outstanding convertible promissory notes are summarized as follows:

Convertible Promissory Notes	$	165,880
Less current portion		-
Total long-term liabilities	$	165,880

Maturities of long-term debt for the next four years are as follows:

Year Ending
September 30,
2023		165,880
	$	165,880

We record the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the notes.

At March 31, 2022, the fair value of the derivative liability was $2,400,203.

Risk free interest rate		Between 0.73%and 2.28%
Stock volatility factor		Between 144.0% and 336.0%
Months to Maturity		0 - 5 years
Expected dividend yield		None

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 20 R11.htm IDEA: XBRL DOCUMENT

CONVERTIBLE LOAN PAYABLE

6 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Short-Term Debt [Text Block]

5. CONVERTIBLE LOAN PAYABLE

XML 21 R12.htm IDEA: XBRL DOCUMENT

WARRANTS

6 Months Ended

Mar. 31, 2022

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-Based Payments [Text Block]

6. WARRANTS

At March 31, 2022, and September 30, 2021, the fair value of the derivative liability warrants was $597,997 and $372,643, respectively.

Risk free interest rate		2.42%
Stock volatility factor		Between 140% and 145%
Months to Maturity		5 years
Expected dividend yield		None

XML 22 R13.htm IDEA: XBRL DOCUMENT

OPTIONS

6 Months Ended

Mar. 31, 2022

Share-Based Payment Arrangement [Abstract]

Share-Based Payment Arrangement [Text Block]

7. OPTIONS

At March 31, 2022, the weighted average remaining contractual life of options outstanding:

March 31, 2022

Weighted

Average

Remaining

Exercisable

Options

Contractual

Prices

Outstanding

Exercisable

Life (years)

0.01

2,000,000

8.41

XML 23 R14.htm IDEA: XBRL DOCUMENT

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

6 Months Ended

Mar. 31, 2022

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities consisted of the following at March 31, 2022 and September 30, 2021:

	03/31/2022		9/30/2021
Trade accounts payable	$	161,922	$	143,074
Credit cards payable		66,894		66,894
Accrued liabilities and interest on notes payable		105,783		356,683
Accrued payroll		11,268		10,712
Deferred compensation		270,433		201,383
License fees payable		36,912		40,402
		653,212		819,148

XML 24 R15.htm IDEA: XBRL DOCUMENT

BRIDGE LOANS PAYABLE - RELATED PARTIES

6 Months Ended

Mar. 31, 2022

Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]

Other Liabilities Disclosure [Text Block]

9. BRIDGE LOANS PAYABLE

Related Parties

Service Provider

XML 25 R16.htm IDEA: XBRL DOCUMENT

DUE TO RELATED PARTY

6 Months Ended

Mar. 31, 2022

Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]

Other Liabilities [Table Text Block]

10. DUE TO RELATED PARTY

XML 26 R17.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

11. COMMITMENTS AND CONTINGENCIES

XML 27 R18.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS

6 Months Ended

Mar. 31, 2022

12. RELATED PARTY TRANSACTIONS

XML 28 R19.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS

6 Months Ended

Mar. 31, 2022

Subsequent Events [Abstract]

Subsequent Events [Text Block]

13. SUBSEQUENT EVENTS

Management has evaluated subsequent events as of May 13, 2022, the date the consolidated financial statements were available to be issued according to the requirements of ASC topic 855.

XML 29 R20.htm IDEA: XBRL DOCUMENT

Accounting Policies, by Policy (Policies)

6 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

Property and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives:

Leasehold improvements	Length of the lease
Computer software and equipment	3 Years
Furniture & fixtures	5 Years
Machinery & equipment	5 Years

The Company capitalizes property and equipment over $500. Property and equipment under $500 are expensed in the year purchased.

Share-Based Payment Arrangement [Policy Text Block]

Stock-Based Compensation

Earnings Per Share, Policy [Policy Text Block]

Net Earnings (Loss) per Share Calculations

	For the three months ended						For the six months ended
	March 31,						March 31,
	2022			2021			2022			2021
Loss to common shareholders (Numerator)	$	(1,229,785	)	$	(669,206	)	$	(1,373,093	)	$	(514,092	)

Basic weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Diluted weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments

●

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

●

	Total		(Level 1)		(Level 2)		(Level 3)

Assets:	$	-	$	-	$	-	$	-

Liabilities:

Derivative Liability at fair value as of September 30, 2021	$	2,553,979	$	-	$	-	$	2,553,979
Derivative Liability warrants at fair value as of September 30, 2021	$	372,643	$	-	$	-	$	372,643
Derivative Liability at fair value as of March 31, 2022	$	2,400,203	$	-	$	-	$	2,400,203
Derivative Liability warrants at fair value as of March 31, 2022	$	597,997	$	-	$	-	$	597,997

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

	Derivative Liability			Derivative Liability Warrants
Balance as of September 30, 2021		2,553,979			372,643
Extinguishment of derivatives		(96,205	)		-
Initial derivative liabilities		134,384			-
Net (Gain)/Loss on change in fair value of derivative liability		(191,955	)		225,354
Ending balance as of March 31, 2022	$	2,400,203		$	597,997

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

- Definition

Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.

+ References + Details

XML 30 R21.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Property, Plant and Equipment [Table Text Block]

Property and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives:

Leasehold improvements	Length of the lease
Computer software and equipment	3 Years
Furniture & fixtures	5 Years
Machinery & equipment	5 Years

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	For the three months ended						For the six months ended
	March 31,						March 31,
	2022			2021			2022			2021
Loss to common shareholders (Numerator)	$	(1,229,785	)	$	(669,206	)	$	(1,373,093	)	$	(514,092	)

Basic weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Diluted weighted average number of common shares outstanding (Denominator)		15,379,289			12,455,164			14,914,920			9,099,121

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Total		(Level 1)		(Level 2)		(Level 3)

Assets:	$	-	$	-	$	-	$	-

Liabilities:

Derivative Liability at fair value as of September 30, 2021	$	2,553,979	$	-	$	-	$	2,553,979
Derivative Liability warrants at fair value as of September 30, 2021	$	372,643	$	-	$	-	$	372,643
Derivative Liability at fair value as of March 31, 2022	$	2,400,203	$	-	$	-	$	2,400,203
Derivative Liability warrants at fair value as of March 31, 2022	$	597,997	$	-	$	-	$	597,997

Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

	Derivative Liability			Derivative Liability Warrants
Balance as of September 30, 2021		2,553,979			372,643
Extinguishment of derivatives		(96,205	)		-
Initial derivative liabilities		134,384			-
Net (Gain)/Loss on change in fair value of derivative liability		(191,955	)		225,354
Ending balance as of March 31, 2022	$	2,400,203		$	597,997

XML 31 R22.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES (Tables)

6 Months Ended

Mar. 31, 2022

CONVERTIBLE PROMISSORY NOTES (Tables) [Line Items]

Schedule of Debt [Table Text Block]

As of March 31, 2022, the outstanding convertible promissory notes are summarized as follows:

Convertible Promissory Notes	$	165,880
Less current portion		-
Total long-term liabilities	$	165,880

Schedule of Maturities of Long-Term Debt [Table Text Block]

Maturities of long-term debt for the next four years are as follows:

Year Ending
September 30,
2023		165,880
	$	165,880

Convertible Debt [Member]

CONVERTIBLE PROMISSORY NOTES (Tables) [Line Items]

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Risk free interest rate		Between 0.73%and 2.28%
Stock volatility factor		Between 144.0% and 336.0%
Months to Maturity		0 - 5 years
Expected dividend yield		None

XML 32 R23.htm IDEA: XBRL DOCUMENT

WARRANTS (Tables)

6 Months Ended

Mar. 31, 2022

Warrant [Member]

WARRANTS (Tables) [Line Items]

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Risk free interest rate		2.42%
Stock volatility factor		Between 140% and 145%
Months to Maturity		5 years
Expected dividend yield		None

XML 33 R24.htm IDEA: XBRL DOCUMENT

OPTIONS (Tables)

6 Months Ended

Mar. 31, 2022

Share-Based Payment Arrangement [Abstract]

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

At March 31, 2022, the weighted average remaining contractual life of options outstanding:

March 31, 2022

Weighted

Average

Remaining

Exercisable

Options

Contractual

Prices

Outstanding

Exercisable

Life (years)

0.01

2,000,000

8.41

XML 34 R25.htm IDEA: XBRL DOCUMENT

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)

6 Months Ended

Mar. 31, 2022

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Accounts payable and accrued liabilities consisted of the following at March 31, 2022 and September 30, 2021:

	03/31/2022		9/30/2021
Trade accounts payable	$	161,922	$	143,074
Credit cards payable		66,894		66,894
Accrued liabilities and interest on notes payable		105,783		356,683
Accrued payroll		11,268		10,712
Deferred compensation		270,433		201,383
License fees payable		36,912		40,402
		653,212		819,148

XML 35 R26.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment	6 Months Ended
	Mar. 31, 2022
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Life	Length of the lease
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Life	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Life	5 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Life	5 years

XML 36 R27.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Schedule of Earnings Per Share, Basic and Diluted [Abstract]
Loss to common shareholders (Numerator) (in Dollars)	$ (1,229,785)	$ (669,206)	$ (1,373,093)	$ (514,092)
Basic weighted average number of common shares outstanding (Denominator)	15,379,289	12,455,164	14,914,920	9,099,121
Diluted weighted average number of common shares outstanding (Denominator)	15,379,289	12,455,164	14,914,920	9,099,121

- Definition

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

XML 37 R28.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($)	Mar. 31, 2022	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Assets:		$ 0
Liabilities:
Derivative Liability at fair value	$ 2,400,203	2,553,979
Derivative Liability warrants at fair value	597,997	372,643
Fair Value, Inputs, Level 1 [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Assets:		0
Liabilities:
Derivative Liability at fair value	0	0
Derivative Liability warrants at fair value	0	0
Fair Value, Inputs, Level 2 [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Assets:		0
Liabilities:
Derivative Liability at fair value	0	0
Derivative Liability warrants at fair value	0	0
Fair Value, Inputs, Level 3 [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Assets:		0
Liabilities:
Derivative Liability at fair value	2,400,203	2,553,979
Derivative Liability warrants at fair value	$ 597,997	$ 372,643

XML 38 R29.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation - Fair Value, Inputs, Level 3 [Member]	6 Months Ended
	Mar. 31, 2022 USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	$ 2,553,979
Extinguishment of derivatives	(96,205)
Initial derivative liabilities	134,384
Net (Gain)/Loss on change in fair value of derivative liability	(191,955)
Balance	2,400,203
Embedded Derivative Financial Instruments [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	372,643
Extinguishment of derivatives	0
Initial derivative liabilities	0
Net (Gain)/Loss on change in fair value of derivative liability	225,354
Balance	$ 597,997

XML 39 R30.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK (Details) - USD ($)					6 Months Ended
CAPITAL STOCK (Details) - USD ($)	Mar. 14, 2022	Jan. 31, 2022	Sep. 04, 2020	Aug. 25, 2020	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021
CAPITAL STOCK (Details) [Line Items]
Common Stock, Shares Authorized					2,000,000,000		2,000,000,000
Preferred Stock, Shares Authorized					50,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)					$ 0.01		$ 0.01
Conversion of Stock, Shares Converted					24,400
Stock Issued During Period, Shares, Other					3,119,643	11,252,850
Stock Issued During Period, Value, Issued for Services (in Dollars)					$ 73,861	$ 145,941
Conversion of Stock, Shares Issued		1,502,670			1,502,670
Stockholders' Equity, Reverse Stock Split				1-for-1,000
Stock Issued During Period, Shares, Issued for Services					265,973	311,945
Stock Issued During Period, Shares, New Issues					791,000	1,440,905
Stockholders' Equity, Other Shares					300,000
Stock Issued During Period, Shares, Conversion of Convertible Securities					250,000
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture					10,000	9,500,000
Proceeds from Issuance of Common Stock (in Dollars)					$ 175,200	$ 295,000
Related Party Transaction, Amounts of Transaction (in Dollars)						$ 936,000
Preferred Stock, Shares Issued					25,000		25,000
Series B Preferred Stock [Member]
CAPITAL STOCK (Details) [Line Items]
Preferred Stock, Shares Authorized					25,000		25,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)			$ 0.01
Preferred Stock, Shares Outstanding					600
Conversion of Stock, Shares Converted					5,000
Stock Issued During Period, Shares, Other					24,400
Conversion of Stock, Shares Issued			25,000
Preferred Stock, Voting Rights			Each share of outstanding Series B Preferred Stock entitles the holder to cast 40,000 votes.
Preferred Stock, Conversion Basis			Each share of Series B Preferred Stock is convertible at the option of the holder into 10,000 common shares
Stock Issued During Period, Shares, New Issues					600
Preferred Stock, Shares Issued					600
Series B Preferred Stock [Member] \| TN3, LLC [Member]
CAPITAL STOCK (Details) [Line Items]
Stock Issued During Period, Shares, Other	24,400
Series A Preferred Stock [Member]
CAPITAL STOCK (Details) [Line Items]
Stock Issued During Period, Value, Issued for Services (in Dollars)					$ 50
Series A Preferred Stock [Member] \| TN3, LLC [Member]
CAPITAL STOCK (Details) [Line Items]
Stock Issued During Period, Shares, Other					5,000
Irvin Consulting, LLC ("IC") [Member] \| Series B Preferred Stock [Member] \| TN3, LLC [Member]
CAPITAL STOCK (Details) [Line Items]
Stock Issued During Period, Shares, Other	600

XML 40 R31.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES (Details) - USD ($)							1 Months Ended	2 Months Ended	3 Months Ended		6 Months Ended		19 Months Ended
CONVERTIBLE PROMISSORY NOTES (Details) - USD ($)	Feb. 16, 2022	Jul. 06, 2021	Jun. 02, 2021	May 10, 2017	Oct. 20, 2015	Nov. 20, 2014	Dec. 31, 2021	Sep. 18, 2017	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2016	Dec. 30, 2021	Oct. 05, 2021	Sep. 30, 2021	Aug. 20, 2021	Mar. 31, 2016
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Face Amount																		$ 12,000
Proceeds from Convertible Debt											$ (94,250)	$ 0
Gain (Loss) on Extinguishment of Debt							$ (37,500)		$ (54,813)	$ 0	(54,813)	$ 0
Derivative Liability, Current									2,400,203		2,400,203					$ 2,553,979
June Note [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Debt Instrument, Face Amount			$ 55,500
Debt Instrument, Convertible, Terms of Conversion Feature			The June Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion.
Convertible Debt									0		0
Debt Instrument, Fee Amount															$ 17,520
Amortization of Debt Discount (Premium)											36,493
Amortization of Debt Issuance Costs											1,458
Gain (Loss) on Extinguishment of Debt											59,915
July Note [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Face Amount		$ 38,750
Debt Instrument, Convertible, Terms of Conversion Feature		The July Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion.
Convertible Debt									0		0
Debt Instrument, Fee Amount														$ 16,936
Amortization of Debt Discount (Premium)											29,620
Amortization of Debt Issuance Costs											1,996
Gain (Loss) on Extinguishment of Debt											36,289
August Note [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																	10.00%
Debt Instrument, Face Amount																	$ 500,000
Convertible Debt									500,000		500,000
Amortization of Debt Discount (Premium)											391,319
Amortization of Debt Issuance Costs											75,000
Amortization of Deferred Loan Origination Fees, Net											34,181
February Note [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Debt Instrument, Face Amount	$ 250,000
Debt Instrument, Convertible, Terms of Conversion Feature	converted, only following an event of default, and therefore is not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period
Convertible Debt									250,000		250,000
Amortization of Debt Discount (Premium)											32,849
Amortization of Debt Issuance Costs											9,250
Amortization of Deferred Loan Origination Fees, Net											19,654
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net									134,384		134,384
Debt Issuance Costs, Net									37,000		37,000
Debt Issuance Costs, Gross									78,616		78,616
Convertible Debt [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				10.00%
Debt Instrument, Face Amount				$ 150,000
Debt Instrument, Convertible, Terms of Conversion Feature								The 2017 Note may be converted by the lender into shares of common stock of the Company at the lesser of $10 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity
Proceeds from Convertible Debt				$ 25,000				$ 90,000
Convertible Debt									115,000		115,000
Debt Instrument, Maturity Date, Description								The 2017 Note matured twelve months from each tranche. Within thirty (30) days prior to the maturity date, the lender may extend the maturity date to sixty (60) months
Convertible Debt [Member] \| Convertible Note Payable Two [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						10.00%
Debt Instrument, Face Amount						$ 400,000
Debt Instrument, Term						18 months
Debt Instrument, Convertible, Terms of Conversion Feature						The 2014 Note may be converted by the lender into shares of common stock of the Company at the lesser of $12.50 per share or (b) fifty percent (50%) of the lowest trade prices following issuance of the 2014 Note or (c) the lowest effective price per share granted to any person or entity
Proceeds from Convertible Debt						$ 50,000							$ 350,000
Convertible Debt									$ 50,880		$ 50,880
Convertible Debt [Member] \| Convertible Note Payable One [Member]
CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature					converted, only following an event of default, and therefore not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period

XML 41 R32.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Debt	Mar. 31, 2022 USD ($)
Schedule of Debt [Abstract]
Convertible Promissory Notes	$ 165,880
Less current portion	0
Total long-term liabilities	$ 165,880

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

XML 42 R33.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Maturities of Long-term Debt	Mar. 31, 2022 USD ($)
Schedule of Maturities of Long-term Debt [Abstract]
2023	$ 165,880
$	$ 165,880

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

XML 43 R34.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques - Embedded Derivative Financial Instruments [Member]	Mar. 31, 2022
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	0
Minimum [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	0.0073
Minimum [Member] \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	1.44
Minimum [Member] \| Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	0
Maximum [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	0.0228
Maximum [Member] \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	3.36
Maximum [Member] \| Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Input	5

XML 44 R35.htm IDEA: XBRL DOCUMENT

CONVERTIBLE LOAN PAYABLE (Details) - USD ($)		6 Months Ended
CONVERTIBLE LOAN PAYABLE (Details) - USD ($)	Oct. 01, 2014	Mar. 31, 2022	Mar. 31, 2016
Debt Disclosure [Abstract]
Debt Instrument, Face Amount			$ 12,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)			$ 4.5
Interest Expense, Debt	$ 1,200	$ 226

XML 45 R36.htm IDEA: XBRL DOCUMENT

WARRANTS (Details) - USD ($)	Feb. 16, 2022	Aug. 20, 2021	Mar. 31, 2022	Sep. 30, 2021
Disclosure Text Block Supplement [Abstract]
Class of Warrant or Rights, Granted	500,000	1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.5	$ 1.5
Embedded Derivative, Fair Value of Embedded Derivative Liability			$ 597,997	$ 372,643

XML 46 R37.htm IDEA: XBRL DOCUMENT

WARRANTS (Details) - Fair Value Measurement Inputs and Valuation Techniques	Mar. 31, 2022
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded Derivative Liability, Measurement Input	0.0242
Measurement Input, Price Volatility [Member] \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded Derivative Liability, Measurement Input	1.40
Measurement Input, Price Volatility [Member] \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded Derivative Liability, Measurement Input	1.45
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded Derivative Liability, Measurement Input	5
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded Derivative Liability, Measurement Input	0

XML 47 R38.htm IDEA: XBRL DOCUMENT

OPTIONS (Details)	Jun. 02, 2020 $ / shares shares
OPTIONS (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross \| shares	2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period	10 years
Option Post Stock Split [Member]
OPTIONS (Details) [Line Items]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price \| $ / shares	$ 0.01

XML 48 R39.htm IDEA: XBRL DOCUMENT

OPTIONS (Details) - Share-based Payment Arrangement, Option, Exercise Price Range	6 Months Ended
	Mar. 31, 2022 $ / shares shares
Share-based Payment Arrangement, Option, Exercise Price Range [Abstract]
Exercisable Prices (in Dollars per share) \| $ / shares	$ 0.01
Options Outstanding	2,000,000
Options Exercisable	2,000,000
Weighted Average Remaining Contractual Life	8 years 4 months 28 days

XML 49 R40.htm IDEA: XBRL DOCUMENT

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($)	Mar. 31, 2022	Sep. 30, 2021
Schedule of Accounts Payable and Accrued Liabilities [Abstract]
Trade accounts payable	$ 161,922	$ 143,074
Credit cards payable	66,894	66,894
Accrued liabilities	105,783	356,683
Accrued payroll	11,268	10,712
Deferred compensation	270,433	201,383
License fees payable	36,912	40,402
	$ 653,212	$ 819,148

XML 50 R41.htm IDEA: XBRL DOCUMENT

BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) - USD ($)			1 Months Ended	3 Months Ended			6 Months Ended
	Jan. 25, 2022	Oct. 01, 2014	Dec. 31, 2021	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)			125,000
Gain (Loss) on Extinguishment of Debt			$ (37,500)	$ (54,813)		$ 0	$ (54,813)	$ 0
Repayments of Related Party Debt							$ 2,316
Stock Issued During Period, Shares, New Issues (in Shares)							791,000	1,440,905
Interest Costs Capitalized							$ 546
Proceeds from Other Debt			$ 25,000
Interest Expense, Debt		$ 1,200					226
Series B Preferred Stock [Member]
BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Line Items]
Proceeds from Issuance of Convertible Preferred Stock							$ 18,616
Stock Issued During Period, Shares, New Issues (in Shares)							600
CEO and CFO [Member]
BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				10.00%			10.00%
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	125,000
Gain (Loss) on Extinguishment of Debt	$ (17,313)
Interest Paid, Including Capitalized Interest, Operating and Investing Activities					$ 237
Interest Costs Capitalized							$ 546
Notes Payable, Related Parties				$ 4,068			$ 4,068
CEO and CFO [Member] \| Maximum [Member]
BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%			12.00%
Chief Executive Officer [Member]
BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Line Items]
Repayments of Related Party Debt							$ 20,938

XML 51 R42.htm IDEA: XBRL DOCUMENT

DUE TO RELATED PARTY (Details) - USD ($)	6 Months Ended
DUE TO RELATED PARTY (Details) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
DUE TO RELATED PARTY (Details) [Line Items]
Proceeds from Related Party Debt	$ 0	$ 25,000
Imputed Interest	516
Affiliated Entity [Member]
DUE TO RELATED PARTY (Details) [Line Items]
Proceeds from Related Party Debt	$ 86,073

XML 52 R43.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS (Details) - USD ($)				3 Months Ended	6 Months Ended
RELATED PARTY TRANSACTIONS (Details) - USD ($)	Jan. 31, 2022	Oct. 04, 2021	Sep. 04, 2020	Mar. 31, 2022	Mar. 31, 2022	Mar. 31, 2021
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture					10,000	9,500,000
Investment Owned, Balance, Shares	24,400
Conversion of Stock, Shares Issued	1,502,670				1,502,670
Payments to Acquire Investments	$ 250,000
TN3, LLC [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Investment Owned, Balance, Shares	25,000
Payments to Acquire Investments				$ 50,000
Due to Related Parties				$ 200,000	$ 200,000
Irvin Consulting, LLC ("IC") [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Investment Owned, Balance, Shares	600
TN3, LLC [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Agreement, Monthly Amount			$ 30,000
Agreement, Term			3 years
Chief Financial Officer [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture		10,000
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture		$ 8,000

XML 53 R44.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details) - Subsequent Event [Member]	May 05, 2022 USD ($)
SUBSEQUENT EVENTS (Details) [Line Items]
Debt Instrument, Face Amount (in Dollars)	$ 1
Repayments of Debt (in Dollars)	$ 500,000
Debt, Original Issue Discount Rate	10.00%
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Maturity Date, Description	The note is due on November 5, 2022, but may be extended for six months by NovAccess
Debt Instrument, Description	NovAccess must repay the note with the proceeds of any loan or capital raise exceeding $5.0 million and may otherwise prepay the note at any time without penalty
Debt, Default Interest Rate	18.00%
Debt Instrument, Fee	Also pursuant to the SPA, NovAccess paid AJB a commitment fee of 875,000 unregistered shares of the company’s common stock (the “commitment fee shares”). If, after May 5, 2023 and before May 5, 2025, AJB is unable to sell the commitment fee shares for $700,000, then AJB may require NovAccess to issue additional shares or pay cash in the amount of the shortfall. However, if NovAccess pays the note off before November 5, 2022, then the company may redeem 437,500 of the commitment shares for one dollar. Pursuant to the SPA, NovAccess also issued to AJB a common stock purchase warrant (the “warrant”) to purchase 1.0 million shares of the company’s common stock for $0.01 a share. The warrant expires on May 5, 2027. NovAccess also entered into a security agreement with AJB (the “security agreement”) pursuant to which NovAccess granted to AJB a security interest in all of the company’s assets, including the equity of StemVax, LLC, securing NovAccess’ obligations under the SPA, note and warrant. In addition, NovAccess entered into a registration rights agreement with AJB (the “registration agreement”) pursuant to which NovAccess agreed to file with the Securities and Exchange Commission a Form S-1 by August 3, 2022 to register for resale the commitment fee shares and the shares issuable upon exercise of the warrant.
Maximum [Member]
SUBSEQUENT EVENTS (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	15.00%

XML 54 novaccess20220331_10q_htm.xml IDEA: XBRL DOCUMENT 0001039466 2021-10-01 2022-03-31 0001039466 2022-05-13 0001039466 2022-03-31 0001039466 2021-09-30 0001039466 us-gaap:SeriesBPreferredStockMember 2022-03-31 0001039466 us-gaap:SeriesBPreferredStockMember 2021-09-30 0001039466 2022-01-01 2022-03-31 0001039466 2021-01-01 2021-03-31 0001039466 2020-10-01 2021-03-31 0001039466 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-09-30 0001039466 us-gaap:CommonStockMember 2020-09-30 0001039466 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001039466 xsnx:AdditionalPaidInCapitalStockOptionsWarrantsMember 2020-09-30 0001039466 us-gaap:RetainedEarningsMember 2020-09-30 0001039466 xsnx:AdditionalPaidInCapitalPreferredStockMember 2020-09-30 0001039466 2020-09-30 0001039466 us-gaap:CommonStockMember 2020-10-01 2021-03-31 0001039466 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2021-03-31 0001039466 xsnx:AdditionalPaidInCapitalPreferredStockMember 2020-10-01 2021-03-31 0001039466 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0001039466 us-gaap:CommonStockMember 2021-03-31 0001039466 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001039466 xsnx:AdditionalPaidInCapitalStockOptionsWarrantsMember 2021-03-31 0001039466 us-gaap:RetainedEarningsMember 2021-03-31 0001039466 xsnx:AdditionalPaidInCapitalPreferredStockMember 2021-03-31 0001039466 2021-03-31 0001039466 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001039466 us-gaap:CommonStockMember 2021-09-30 0001039466 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001039466 xsnx:AdditionalPaidInCapitalStockOptionsWarrantsMember 2021-09-30 0001039466 us-gaap:RetainedEarningsMember 2021-09-30 0001039466 xsnx:AdditionalPaidInCapitalPreferredStockMember 2021-09-30 0001039466 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-10-01 2022-03-31 0001039466 us-gaap:CommonStockMember 2021-10-01 2022-03-31 0001039466 us-gaap:RetainedEarningsMember 2021-10-01 2022-03-31 0001039466 xsnx:CommonStockIssuableMember us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2022-03-31 0001039466 xsnx:CommonStockIssuableMember 2021-10-01 2022-03-31 0001039466 xsnx:AdditionalPaidInCapitalPreferredStockMember 2021-10-01 2022-03-31 0001039466 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001039466 us-gaap:CommonStockMember 2022-03-31 0001039466 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001039466 xsnx:AdditionalPaidInCapitalStockOptionsWarrantsMember 2022-03-31 0001039466 us-gaap:RetainedEarningsMember 2022-03-31 0001039466 xsnx:AdditionalPaidInCapitalPreferredStockMember 2022-03-31 0001039466 us-gaap:LeaseholdImprovementsMember 2021-10-01 2022-03-31 0001039466 us-gaap:ComputerEquipmentMember 2021-10-01 2022-03-31 0001039466 us-gaap:FurnitureAndFixturesMember 2021-10-01 2022-03-31 0001039466 us-gaap:MachineryAndEquipmentMember 2021-10-01 2022-03-31 0001039466 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001039466 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001039466 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001039466 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001039466 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001039466 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001039466 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001039466 us-gaap:FairValueInputsLevel3Member 2021-10-01 2022-03-31 0001039466 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:FairValueInputsLevel3Member 2021-10-01 2022-03-31 0001039466 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001039466 us-gaap:SeriesBPreferredStockMember 2021-10-01 2022-03-31 0001039466 us-gaap:SeriesAPreferredStockMember 2021-10-01 2022-03-31 0001039466 xsnx:TN3LLCMember us-gaap:SeriesAPreferredStockMember 2021-10-01 2022-03-31 0001039466 us-gaap:SeriesBPreferredStockMember 2020-09-04 2020-09-04 0001039466 us-gaap:SeriesBPreferredStockMember 2020-09-04 0001039466 xsnx:TN3LLCMember us-gaap:SeriesBPreferredStockMember 2022-03-14 2022-03-14 0001039466 xsnx:TN3LLCMember us-gaap:SeriesBPreferredStockMember xsnx:IrvinConsultingLLCICMember 2022-03-14 2022-03-14 0001039466 2020-08-25 2020-08-25 0001039466 xsnx:ConvertibleNotePayableTwoMember us-gaap:ConvertibleDebtMember 2014-11-20 0001039466 xsnx:ConvertibleNotePayableTwoMember us-gaap:ConvertibleDebtMember 2014-11-20 2014-11-20 0001039466 xsnx:ConvertibleNotePayableTwoMember us-gaap:ConvertibleDebtMember 2015-02-18 2016-09-30 0001039466 xsnx:ConvertibleNotePayableTwoMember us-gaap:ConvertibleDebtMember 2022-03-31 0001039466 us-gaap:ConvertibleDebtMember 2017-05-10 0001039466 us-gaap:ConvertibleDebtMember 2017-05-10 2017-05-10 0001039466 us-gaap:ConvertibleDebtMember 2017-07-31 2017-09-18 0001039466 us-gaap:ConvertibleDebtMember 2022-03-31 0001039466 xsnx:JuneNoteMember 2021-06-02 0001039466 xsnx:JuneNoteMember 2021-06-02 2021-06-02 0001039466 xsnx:JuneNoteMember 2021-10-05 0001039466 xsnx:JuneNoteMember 2021-10-01 2022-03-31 0001039466 xsnx:JuneNoteMember 2022-03-31 0001039466 xsnx:JulyNoteMember 2021-07-06 0001039466 xsnx:JulyNoteMember 2021-07-06 2021-07-06 0001039466 xsnx:JulyNoteMember 2021-12-30 0001039466 xsnx:JulyNoteMember 2021-10-01 2022-03-31 0001039466 xsnx:JulyNoteMember 2022-03-31 0001039466 xsnx:AugustNoteMember 2021-08-20 0001039466 xsnx:ConvertibleNotePayableOneMember us-gaap:ConvertibleDebtMember 2015-10-20 2015-10-20 0001039466 xsnx:AugustNoteMember 2021-10-01 2022-03-31 0001039466 xsnx:AugustNoteMember 2022-03-31 0001039466 xsnx:FebruaryNoteMember 2022-02-16 0001039466 xsnx:FebruaryNoteMember 2022-02-16 2022-02-16 0001039466 xsnx:FebruaryNoteMember 2021-10-01 2022-03-31 0001039466 xsnx:FebruaryNoteMember 2022-03-31 0001039466 us-gaap:ConvertibleDebtMember 2021-10-01 2022-03-31 0001039466 pf0:MinimumMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001039466 pf0:MaximumMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001039466 pf0:MinimumMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001039466 pf0:MaximumMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001039466 pf0:MinimumMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputExpectedTermMember 2022-03-31 0001039466 pf0:MaximumMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputExpectedTermMember 2022-03-31 0001039466 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-03-31 0001039466 2016-03-31 0001039466 2014-10-01 2014-10-01 0001039466 2021-08-20 2021-08-20 0001039466 2021-08-20 0001039466 2022-02-16 2022-02-16 0001039466 2022-02-16 0001039466 us-gaap:WarrantMember 2021-10-01 2022-03-31 0001039466 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001039466 pf0:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001039466 pf0:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001039466 us-gaap:MeasurementInputExpectedTermMember 2022-03-31 0001039466 us-gaap:MeasurementInputExpectedDividendRateMember 2022-03-31 0001039466 2020-06-02 2020-06-02 0001039466 xsnx:OptionPostStockSplitMember 2020-06-02 2020-06-02 0001039466 xsnx:CEOAndCFOMember 2022-03-31 0001039466 pf0:MaximumMember xsnx:CEOAndCFOMember 2022-03-31 0001039466 xsnx:CEOAndCFOMember 2022-01-25 2022-01-25 0001039466 xsnx:CEOAndCFOMember 2021-10-01 2021-12-31 0001039466 pf0:ChiefExecutiveOfficerMember 2021-10-01 2022-03-31 0001039466 xsnx:CEOAndCFOMember 2021-10-01 2022-03-31 0001039466 2021-12-01 2021-12-31 0001039466 pf0:AffiliatedEntityMember 2021-10-01 2022-03-31 0001039466 xsnx:TN3LLCMember 2020-09-04 2020-09-04 0001039466 pf0:ChiefFinancialOfficerMember 2021-10-04 2021-10-04 0001039466 xsnx:TN3LLCMember 2022-01-31 0001039466 2022-01-31 0001039466 xsnx:IrvinConsultingLLCICMember 2022-01-31 0001039466 2022-01-31 2022-01-31 0001039466 xsnx:TN3LLCMember 2022-01-01 2022-03-31 0001039466 xsnx:TN3LLCMember 2022-03-31 0001039466 us-gaap:SubsequentEventMember 2022-05-05 0001039466 us-gaap:SubsequentEventMember 2022-05-05 2022-05-05 0001039466 pf0:MaximumMember us-gaap:SubsequentEventMember 2022-05-05 shares iso4217:USD iso4217:USD shares pure 10-Q true 2022-03-31 false 000-29621 NovAccess Global Inc. CO 84-1384159 8584 E. Washington Street #127 Chagrin Falls OH 44023 213 642-9268 N/A N/A Yes Yes Non-accelerated Filer true false false 18398673

61609

180668

380

21898

27086

83507

208134

161922

143074

66894

105783

356683

11268

10712

270433

201383

36912

40402

2400203

2553979

597997

372643

86073

82922

200000

188247

395027

561753

104973

4608

12000

69567

24683

4515846

3970348

165880

4681726

4136228

0.01

25000

250

2000000000

17523673

14404030

42921963

41882535

5356398

5351398

4210960 4210960

4747108

5088324

-61834654

-60461561

-4598219

-3928094

83507

208134

45516

8446

87915

8446

381428

272873

661358

1672764

426944

281319

749273

1681210

-426944

-281319

-749273

-1681210

-492425

-382539

-33399

1180067

96205

-54813

255603

5348

631813

12949

-802841

-387887

-623820

1167118

-1229785

-669206

-1373093

-514092

-0.08

-0.05

-0.09

-0.06

-0.08

-0.05

-0.09

-0.06

15379289

12455164

14914920

9099121

15379289

12455164

14914920

9099121

25000

250

1603492

33369424

11710398

4210960

5088324

-57949086

-3569730

7500000

6375000

-6375000

2000000

936000

311945

145941

1440905

295000

-514092

25000

250

12856342

41121365

5335398

4210960

5088324

-58463178

-2706881

25000

250

14404030

41882535

5351398

4210960

5088324

-60461561

-3928094

-24400

-244

1502670

525935

-341216

184475

10000

8000

265973

119480

73861

791000

170200

250000

104813

50000

300000

111000

5000

-1373093

600

17523673

42921963

5356398

4210960

4747108

-61834654

-4598219

-1373093

-514092

479689

-33399 1180067

96205

-54813

53619

936000

73861

145941

79043

546

-380

-5188

39700

163310

1590

-3490

-10000

144100

32999

556

23290

69050

120508

-438844

-280521

175200

295000

3151

6628

213000

50000

-94250

75000

2316

25000

24287

319785

302341

-119059

21820

180668

178

61609

21998

71245

1386

546 2505

6375000

200000

1. ORGANIZATION AND LINE OF BUSINESS OrganizationNovAccess Global Inc. (“NovAccess,” the “Company”) is a Colorado corporation formerly known as Sun River Mining Inc. and XsunX, Inc. The Company was originally incorporated in Colorado on February 25, 1997. Effective September 24, 2003, the Company completed a plan of reorganization and name change to XsunX, Inc. In June 2020, the Company was acquired and changed its name to NovAccess Global Inc. Line of BusinessNovAccess Global Inc. is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We specialize in cutting-edge research related to utilizing a patient’s own immune system to attack the cancer. We are filing an Investigational New Drug Application (IND) and working closely with the Food and Drug Administration (FDA) to obtain approval for human clinical trials to determine safety and efficacy of our drug product for brain cancer patients. Once we have successfully completed the clinical trials and proven that the new therapy is safe and efficacious, we plan to commercialize the product. We also have expertise in successfully executing clinical trials, bringing products to market and increasing the market size of products through our advisory board. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecules development, gene therapy and other technical assays needed for protein and genetic analysis of cancer cells. NovAccess operates as a research and development (R&D) company out of Ohio and California, and our executive management and scientific advisory board provide over 15 years of extensive experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates. We guide our performance by striving to deliver consistently on the following core objectives: (1) Accountability — taking responsibility for providing safe and effective options for patients; (2) Integrity — doing what is ethically right for the patient; (3) Excellence — doing your best and working hard; and (4) Teamwork — bringing together a strong working team to deliver the best products for brain tumor patients. Basis of PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the six months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ended September 30, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended September 30, 2021. Going ConcernThe accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders and lenders since its inception through the period ended March 31, 2022. Management believes the existing shareholders and the prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its business. This summary of significant accounting policies of NovAccess is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of PresentationThe consolidated financial statements include the accounts of the Company and its wholly owned subsidiary StemVax, LLC. All significant inter-company accounts and transactions between these entities have been eliminated in these condensed consolidated financial statements. Use of EstimatesThe preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements. Significant estimates made in preparing these consolidated financial statements include the estimate of derivative liabilities, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates. Cash and Cash Equivalents For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less. Property and EquipmentProperty and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:middle;width:30.2%;"> Leasehold improvements </td> <td style="vertical-align:top;width:19.6%;"> Length of the lease </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Computer software and equipment </td> <td style="vertical-align:top;width:19.6%;"> 3 Years </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Furniture & fixtures </td> <td style="vertical-align:top;width:19.6%;"> 5 Years </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Machinery & equipment </td> <td style="vertical-align:top;width:19.6%;"> 5 Years </td> </tr> </table> The Company capitalizes property and equipment over $500. Property and equipment under $500 are expensed in the year purchased. Stock-Based CompensationShare-based Payment applies to transactions in which an entity exchanges its equity instruments for goods or services and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We are required to follow a fair value approach using an option-pricing model, such as the Binomial lattice valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option. This has not had a material impact on our results of operations. Net Earnings (Loss) per Share CalculationsNet earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the period. Diluted net earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the effect of stock options and stock-based awards plus the assumed conversion of convertible debt (Notes 4 and 5).  <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2863" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2864" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> For the three months ended </td> <td id="new_id-2865" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2866" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2867" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> For the six months ended </td> <td id="new_id-2868" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2869" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2870" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> March 31, </td> <td id="new_id-2871" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2872" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2873" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> March 31, </td> <td id="new_id-2874" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2875" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2876" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td id="new_id-2877" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2878" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2879" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td id="new_id-2880" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2881" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2882" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td id="new_id-2883" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2884" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2885" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td id="new_id-2886" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 52%;"> Loss to common shareholders (Numerator) </td> <td id="new_id-2887" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2888" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2889" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,229,785</td> <td id="new_id-2890" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2891" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2892" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2893" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(669,206</td> <td id="new_id-2894" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2895" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2896" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2897" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,373,093</td> <td id="new_id-2898" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2899" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2900" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2901" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(514,092</td> <td id="new_id-2902" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-2903"> </td> <td id="new_id-2904"> </td> <td id="new_id-2905"> </td> <td id="new_id-2906"> </td> <td id="new_id-2907"> </td> <td id="new_id-2908"> </td> <td id="new_id-2909"> </td> <td id="new_id-2910"> </td> <td id="new_id-2911"> </td> <td id="new_id-2912"> </td> <td id="new_id-2913"> </td> <td id="new_id-2914"> </td> <td id="new_id-2915"> </td> <td id="new_id-2916"> </td> <td id="new_id-2917"> </td> <td id="new_id-2918"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Basic weighted average number of common shares outstanding (Denominator) </td> <td id="new_id-2919" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2920" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2921" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,379,289</td> <td id="new_id-2922" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2923" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2924" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2925" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,455,164</td> <td id="new_id-2926" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2927" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2928" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2929" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,914,920</td> <td id="new_id-2930" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2931" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2932" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2933" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,099,121</td> <td id="new_id-2934" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-2935"> </td> <td id="new_id-2936"> </td> <td id="new_id-2937"> </td> <td id="new_id-2938"> </td> <td id="new_id-2939"> </td> <td id="new_id-2940"> </td> <td id="new_id-2941"> </td> <td id="new_id-2942"> </td> <td id="new_id-2943"> </td> <td id="new_id-2944"> </td> <td id="new_id-2945"> </td> <td id="new_id-2946"> </td> <td id="new_id-2947"> </td> <td id="new_id-2948"> </td> <td id="new_id-2949"> </td> <td id="new_id-2950"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Diluted weighted average number of common shares outstanding (Denominator) </td> <td id="new_id-2951" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2952" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2953" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,379,289</td> <td id="new_id-2954" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2955" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2956" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2957" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,455,164</td> <td id="new_id-2958" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2959" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2960" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2961" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,914,920</td> <td id="new_id-2962" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2963" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2964" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2965" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,099,121</td> <td id="new_id-2966" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table> Diluted weighted average number of shares for the three and six months ended March 31, 2022 and March 31, 2021 is the same as basic weighted average number of shares because the Company had net losses for these respective periods. Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2022, the balances reported for cash, prepaid expenses, accounts payable, accrued expenses approximate the fair value because of their short maturities. We adopted Accounting Standards Codification (“ASC”) Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, an established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align: middle; width: 7%;"> </td> <td style="vertical-align: top; width: 4%;"> ● </td> <td style="vertical-align: top; width: 89%;"> Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align: middle; width: 7%;"> </td> <td style="vertical-align: top; width: 4%;"> ● </td> <td style="vertical-align: top; width: 89%;"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align: middle; width: 7%;"> </td> <td style="vertical-align: top; width: 4%;"> ● </td> <td style="vertical-align: top; width: 89%;"> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </td> </tr> </table> We measure certain financial instruments at fair value on a recurring basis. The Company had no assets that are required to be valued on a recurring basis as of March 31, 2022 and September 30, 2021. The Company had liabilities that are required to be measured at fair value on a recurring basis as follows at March 31, 2022 and September 30, 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2967" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2968" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Total </td> <td id="new_id-2969" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2970" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2971" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 1) </td> <td id="new_id-2972" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2973" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2974" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 2) </td> <td id="new_id-2975" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2976" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2977" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 3) </td> <td id="new_id-2978" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td id="new_id-2979"> </td> <td id="new_id-2980"> </td> <td id="new_id-2981"> </td> <td id="new_id-2982"> </td> <td id="new_id-2983"> </td> <td id="new_id-2984"> </td> <td id="new_id-2985"> </td> <td id="new_id-2986"> </td> <td id="new_id-2987"> </td> <td id="new_id-2988"> </td> <td id="new_id-2989"> </td> <td id="new_id-2990"> </td> <td id="new_id-2991"> </td> <td id="new_id-2992"> </td> <td id="new_id-2993"> </td> <td id="new_id-2994"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 52%;"> Assets: </td> <td id="new_id-2995" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2996" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-2997" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-2998" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2999" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3000" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3001" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3002" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3003" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3004" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3005" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3006" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3007" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3008" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3009" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3010" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-3011"> </td> <td id="new_id-3012"> </td> <td id="new_id-3013"> </td> <td id="new_id-3014"> </td> <td id="new_id-3015"> </td> <td id="new_id-3016"> </td> <td id="new_id-3017"> </td> <td id="new_id-3018"> </td> <td id="new_id-3019"> </td> <td id="new_id-3020"> </td> <td id="new_id-3021"> </td> <td id="new_id-3022"> </td> <td id="new_id-3023"> </td> <td id="new_id-3024"> </td> <td id="new_id-3025"> </td> <td id="new_id-3026"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Liabilities: </td> <td id="new_id-3027" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3028" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3029" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3030" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3031" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3032" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3033" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3034" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3035" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3036" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3037" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3038" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3039" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3040" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3041" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3042" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-3043"> </td> <td id="new_id-3044"> </td> <td id="new_id-3045"> </td> <td id="new_id-3046"> </td> <td id="new_id-3047"> </td> <td id="new_id-3048"> </td> <td id="new_id-3049"> </td> <td id="new_id-3050"> </td> <td id="new_id-3051"> </td> <td id="new_id-3052"> </td> <td id="new_id-3053"> </td> <td id="new_id-3054"> </td> <td id="new_id-3055"> </td> <td id="new_id-3056"> </td> <td id="new_id-3057"> </td> <td id="new_id-3058"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability at fair value as of September 30, 2021 </td> <td id="new_id-3059" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3060" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3061" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553,979</td> <td id="new_id-3062" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3063" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3064" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3065" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3066" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3067" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3068" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3069" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3070" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3071" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3072" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3073" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553,979</td> <td id="new_id-3074" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability warrants at fair value as of September 30, 2021 </td> <td id="new_id-3075" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3076" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3077" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">372,643</td> <td id="new_id-3078" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3079" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3080" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3081" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3082" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3083" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3084" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3085" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3086" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3087" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3088" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3089" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">372,643</td> <td id="new_id-3090" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability at fair value as of March 31, 2022 </td> <td id="new_id-3091" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3092" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3093" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3094" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3095" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3096" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3097" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3098" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3099" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3100" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3101" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3102" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3103" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3104" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3105" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3106" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability warrants at fair value as of March 31, 2022 </td> <td id="new_id-3107" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3108" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3109" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3110" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3111" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3112" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3113" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td id="new_id-3114" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3115" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3116" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3117" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td id="new_id-3118" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3119" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3120" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3121" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3122" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table> The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3123" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3124" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Derivative Liability </td> <td id="new_id-3125" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-3126" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3127" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Derivative Liability Warrants </td> <td id="new_id-3128" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 62%;"> Balance as of September 30, 2021 </td> <td id="new_id-3129" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3130" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3131" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,553,979</td> <td id="new_id-3132" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3133" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3134" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3135" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">372,643</td> <td id="new_id-3136" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Extinguishment of derivatives </td> <td id="new_id-3137" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3138" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3139" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(96,205</td> <td id="new_id-3140" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> ) </td> <td id="new_id-3141" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3142" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3143" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td> <td id="new_id-3144" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Initial derivative liabilities </td> <td id="new_id-3145" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3146" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3147" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">134,384</td> <td id="new_id-3148" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3149" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3150" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3151" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td> <td id="new_id-3152" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Net (Gain)/Loss on change in fair value of derivative liability </td> <td id="new_id-3153" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3154" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3155" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(191,955</td> <td id="new_id-3156" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> ) </td> <td id="new_id-3157" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3158" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3159" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">225,354</td> <td id="new_id-3160" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Ending balance as of March 31, 2022 </td> <td id="new_id-3161" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3162" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3163" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3164" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3165" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3166" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3167" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3168" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table> Recent Accounting Pronouncements In May 2021, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) 2021-04—Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options, to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU are effective for public and nonpublic entities for fiscal years beginning after December 15, 2021, and interim periods with fiscal years beginning after December 15, 2021. Early adoption is permitted, including adoption in an interim period. The Company has evaluated the impact of the adoption of ASU 2021-04, which had no effect on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Basis of PresentationThe consolidated financial statements include the accounts of the Company and its wholly owned subsidiary StemVax, LLC. All significant inter-company accounts and transactions between these entities have been eliminated in these condensed consolidated financial statements.

Use of EstimatesThe preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements. Significant estimates made in preparing these consolidated financial statements include the estimate of derivative liabilities, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.

Cash and Cash Equivalents For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less.

Property and EquipmentProperty and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:middle;width:30.2%;"> Leasehold improvements </td> <td style="vertical-align:top;width:19.6%;"> Length of the lease </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Computer software and equipment </td> <td style="vertical-align:top;width:19.6%;"> 3 Years </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Furniture & fixtures </td> <td style="vertical-align:top;width:19.6%;"> 5 Years </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Machinery & equipment </td> <td style="vertical-align:top;width:19.6%;"> 5 Years </td> </tr> </table> The Company capitalizes property and equipment over $500. Property and equipment under $500 are expensed in the year purchased.

Property and equipment are stated at cost, and are depreciated using the straight-line method over its estimated useful lives: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:middle;width:30.2%;"> Leasehold improvements </td> <td style="vertical-align:top;width:19.6%;"> Length of the lease </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Computer software and equipment </td> <td style="vertical-align:top;width:19.6%;"> 3 Years </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Furniture & fixtures </td> <td style="vertical-align:top;width:19.6%;"> 5 Years </td> </tr> <tr> <td style="vertical-align:middle;width:30.2%;"> Machinery & equipment </td> <td style="vertical-align:top;width:19.6%;"> 5 Years </td> </tr> </table>

Length of the lease

P3Y

P5Y

Stock-Based CompensationShare-based Payment applies to transactions in which an entity exchanges its equity instruments for goods or services and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We are required to follow a fair value approach using an option-pricing model, such as the Binomial lattice valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option. This has not had a material impact on our results of operations

Net Earnings (Loss) per Share CalculationsNet earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the period. Diluted net earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the effect of stock options and stock-based awards plus the assumed conversion of convertible debt (Notes 4 and 5).  <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2863" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2864" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> For the three months ended </td> <td id="new_id-2865" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2866" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2867" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> For the six months ended </td> <td id="new_id-2868" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2869" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2870" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> March 31, </td> <td id="new_id-2871" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2872" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2873" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> March 31, </td> <td id="new_id-2874" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2875" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2876" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td id="new_id-2877" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2878" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2879" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td id="new_id-2880" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2881" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2882" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td id="new_id-2883" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2884" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2885" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td id="new_id-2886" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 52%;"> Loss to common shareholders (Numerator) </td> <td id="new_id-2887" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2888" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2889" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,229,785</td> <td id="new_id-2890" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2891" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2892" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2893" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(669,206</td> <td id="new_id-2894" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2895" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2896" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2897" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,373,093</td> <td id="new_id-2898" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2899" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2900" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2901" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(514,092</td> <td id="new_id-2902" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-2903"> </td> <td id="new_id-2904"> </td> <td id="new_id-2905"> </td> <td id="new_id-2906"> </td> <td id="new_id-2907"> </td> <td id="new_id-2908"> </td> <td id="new_id-2909"> </td> <td id="new_id-2910"> </td> <td id="new_id-2911"> </td> <td id="new_id-2912"> </td> <td id="new_id-2913"> </td> <td id="new_id-2914"> </td> <td id="new_id-2915"> </td> <td id="new_id-2916"> </td> <td id="new_id-2917"> </td> <td id="new_id-2918"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Basic weighted average number of common shares outstanding (Denominator) </td> <td id="new_id-2919" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2920" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2921" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,379,289</td> <td id="new_id-2922" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2923" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2924" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2925" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,455,164</td> <td id="new_id-2926" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2927" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2928" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2929" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,914,920</td> <td id="new_id-2930" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2931" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2932" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2933" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,099,121</td> <td id="new_id-2934" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-2935"> </td> <td id="new_id-2936"> </td> <td id="new_id-2937"> </td> <td id="new_id-2938"> </td> <td id="new_id-2939"> </td> <td id="new_id-2940"> </td> <td id="new_id-2941"> </td> <td id="new_id-2942"> </td> <td id="new_id-2943"> </td> <td id="new_id-2944"> </td> <td id="new_id-2945"> </td> <td id="new_id-2946"> </td> <td id="new_id-2947"> </td> <td id="new_id-2948"> </td> <td id="new_id-2949"> </td> <td id="new_id-2950"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Diluted weighted average number of common shares outstanding (Denominator) </td> <td id="new_id-2951" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2952" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2953" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,379,289</td> <td id="new_id-2954" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2955" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2956" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2957" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,455,164</td> <td id="new_id-2958" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2959" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2960" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2961" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,914,920</td> <td id="new_id-2962" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2963" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2964" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2965" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,099,121</td> <td id="new_id-2966" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table> Diluted weighted average number of shares for the three and six months ended March 31, 2022 and March 31, 2021 is the same as basic weighted average number of shares because the Company had net losses for these respective periods.

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2863" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2864" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> For the three months ended </td> <td id="new_id-2865" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2866" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2867" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> For the six months ended </td> <td id="new_id-2868" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2869" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2870" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> March 31, </td> <td id="new_id-2871" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2872" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" id="new_id-2873" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> March 31, </td> <td id="new_id-2874" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2875" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2876" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td id="new_id-2877" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2878" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2879" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td id="new_id-2880" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2881" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2882" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td id="new_id-2883" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2884" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2885" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td id="new_id-2886" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 52%;"> Loss to common shareholders (Numerator) </td> <td id="new_id-2887" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2888" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2889" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,229,785</td> <td id="new_id-2890" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2891" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2892" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2893" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(669,206</td> <td id="new_id-2894" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2895" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2896" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2897" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,373,093</td> <td id="new_id-2898" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> <td id="new_id-2899" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2900" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-2901" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(514,092</td> <td id="new_id-2902" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-2903"> </td> <td id="new_id-2904"> </td> <td id="new_id-2905"> </td> <td id="new_id-2906"> </td> <td id="new_id-2907"> </td> <td id="new_id-2908"> </td> <td id="new_id-2909"> </td> <td id="new_id-2910"> </td> <td id="new_id-2911"> </td> <td id="new_id-2912"> </td> <td id="new_id-2913"> </td> <td id="new_id-2914"> </td> <td id="new_id-2915"> </td> <td id="new_id-2916"> </td> <td id="new_id-2917"> </td> <td id="new_id-2918"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Basic weighted average number of common shares outstanding (Denominator) </td> <td id="new_id-2919" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2920" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2921" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,379,289</td> <td id="new_id-2922" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2923" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2924" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2925" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,455,164</td> <td id="new_id-2926" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2927" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2928" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2929" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,914,920</td> <td id="new_id-2930" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2931" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2932" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2933" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,099,121</td> <td id="new_id-2934" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-2935"> </td> <td id="new_id-2936"> </td> <td id="new_id-2937"> </td> <td id="new_id-2938"> </td> <td id="new_id-2939"> </td> <td id="new_id-2940"> </td> <td id="new_id-2941"> </td> <td id="new_id-2942"> </td> <td id="new_id-2943"> </td> <td id="new_id-2944"> </td> <td id="new_id-2945"> </td> <td id="new_id-2946"> </td> <td id="new_id-2947"> </td> <td id="new_id-2948"> </td> <td id="new_id-2949"> </td> <td id="new_id-2950"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Diluted weighted average number of common shares outstanding (Denominator) </td> <td id="new_id-2951" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2952" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2953" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,379,289</td> <td id="new_id-2954" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2955" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2956" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2957" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,455,164</td> <td id="new_id-2958" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2959" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2960" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2961" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,914,920</td> <td id="new_id-2962" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2963" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2964" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-2965" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">9,099,121</td> <td id="new_id-2966" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

-1229785

-669206

-1373093

-514092

15379289

12455164

14914920

9099121

15379289

12455164

14914920

9099121

Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2022, the balances reported for cash, prepaid expenses, accounts payable, accrued expenses approximate the fair value because of their short maturities. We adopted Accounting Standards Codification (“ASC”) Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, an established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align: middle; width: 7%;"> </td> <td style="vertical-align: top; width: 4%;"> ● </td> <td style="vertical-align: top; width: 89%;"> Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align: middle; width: 7%;"> </td> <td style="vertical-align: top; width: 4%;"> ● </td> <td style="vertical-align: top; width: 89%;"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align: middle; width: 7%;"> </td> <td style="vertical-align: top; width: 4%;"> ● </td> <td style="vertical-align: top; width: 89%;"> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </td> </tr> </table> We measure certain financial instruments at fair value on a recurring basis. The Company had no assets that are required to be valued on a recurring basis as of March 31, 2022 and September 30, 2021. The Company had liabilities that are required to be measured at fair value on a recurring basis as follows at March 31, 2022 and September 30, 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2967" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2968" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Total </td> <td id="new_id-2969" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2970" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2971" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 1) </td> <td id="new_id-2972" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2973" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2974" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 2) </td> <td id="new_id-2975" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2976" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2977" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 3) </td> <td id="new_id-2978" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td id="new_id-2979"> </td> <td id="new_id-2980"> </td> <td id="new_id-2981"> </td> <td id="new_id-2982"> </td> <td id="new_id-2983"> </td> <td id="new_id-2984"> </td> <td id="new_id-2985"> </td> <td id="new_id-2986"> </td> <td id="new_id-2987"> </td> <td id="new_id-2988"> </td> <td id="new_id-2989"> </td> <td id="new_id-2990"> </td> <td id="new_id-2991"> </td> <td id="new_id-2992"> </td> <td id="new_id-2993"> </td> <td id="new_id-2994"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 52%;"> Assets: </td> <td id="new_id-2995" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2996" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-2997" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-2998" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2999" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3000" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3001" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3002" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3003" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3004" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3005" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3006" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3007" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3008" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3009" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3010" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-3011"> </td> <td id="new_id-3012"> </td> <td id="new_id-3013"> </td> <td id="new_id-3014"> </td> <td id="new_id-3015"> </td> <td id="new_id-3016"> </td> <td id="new_id-3017"> </td> <td id="new_id-3018"> </td> <td id="new_id-3019"> </td> <td id="new_id-3020"> </td> <td id="new_id-3021"> </td> <td id="new_id-3022"> </td> <td id="new_id-3023"> </td> <td id="new_id-3024"> </td> <td id="new_id-3025"> </td> <td id="new_id-3026"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Liabilities: </td> <td id="new_id-3027" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3028" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3029" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3030" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3031" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3032" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3033" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3034" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3035" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3036" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3037" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3038" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3039" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3040" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3041" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3042" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-3043"> </td> <td id="new_id-3044"> </td> <td id="new_id-3045"> </td> <td id="new_id-3046"> </td> <td id="new_id-3047"> </td> <td id="new_id-3048"> </td> <td id="new_id-3049"> </td> <td id="new_id-3050"> </td> <td id="new_id-3051"> </td> <td id="new_id-3052"> </td> <td id="new_id-3053"> </td> <td id="new_id-3054"> </td> <td id="new_id-3055"> </td> <td id="new_id-3056"> </td> <td id="new_id-3057"> </td> <td id="new_id-3058"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability at fair value as of September 30, 2021 </td> <td id="new_id-3059" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3060" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3061" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553,979</td> <td id="new_id-3062" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3063" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3064" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3065" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3066" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3067" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3068" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3069" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3070" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3071" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3072" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3073" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553,979</td> <td id="new_id-3074" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability warrants at fair value as of September 30, 2021 </td> <td id="new_id-3075" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3076" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3077" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">372,643</td> <td id="new_id-3078" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3079" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3080" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3081" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3082" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3083" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3084" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3085" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3086" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3087" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3088" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3089" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">372,643</td> <td id="new_id-3090" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability at fair value as of March 31, 2022 </td> <td id="new_id-3091" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3092" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3093" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3094" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3095" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3096" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3097" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3098" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3099" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3100" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3101" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3102" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3103" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3104" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3105" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3106" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability warrants at fair value as of March 31, 2022 </td> <td id="new_id-3107" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3108" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3109" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3110" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3111" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3112" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3113" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td id="new_id-3114" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3115" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3116" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3117" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td id="new_id-3118" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3119" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3120" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3121" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3122" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table> The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3123" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3124" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Derivative Liability </td> <td id="new_id-3125" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-3126" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3127" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Derivative Liability Warrants </td> <td id="new_id-3128" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 62%;"> Balance as of September 30, 2021 </td> <td id="new_id-3129" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3130" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3131" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,553,979</td> <td id="new_id-3132" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3133" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3134" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3135" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">372,643</td> <td id="new_id-3136" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Extinguishment of derivatives </td> <td id="new_id-3137" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3138" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3139" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(96,205</td> <td id="new_id-3140" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> ) </td> <td id="new_id-3141" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3142" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3143" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td> <td id="new_id-3144" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Initial derivative liabilities </td> <td id="new_id-3145" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3146" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3147" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">134,384</td> <td id="new_id-3148" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3149" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3150" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3151" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td> <td id="new_id-3152" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Net (Gain)/Loss on change in fair value of derivative liability </td> <td id="new_id-3153" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3154" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3155" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(191,955</td> <td id="new_id-3156" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> ) </td> <td id="new_id-3157" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3158" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3159" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">225,354</td> <td id="new_id-3160" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Ending balance as of March 31, 2022 </td> <td id="new_id-3161" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3162" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3163" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3164" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3165" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3166" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3167" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3168" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

We measure certain financial instruments at fair value on a recurring basis. The Company had no assets that are required to be valued on a recurring basis as of March 31, 2022 and September 30, 2021. The Company had liabilities that are required to be measured at fair value on a recurring basis as follows at March 31, 2022 and September 30, 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2967" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2968" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Total </td> <td id="new_id-2969" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2970" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2971" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 1) </td> <td id="new_id-2972" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2973" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2974" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 2) </td> <td id="new_id-2975" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-2976" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-2977" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (Level 3) </td> <td id="new_id-2978" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td id="new_id-2979"> </td> <td id="new_id-2980"> </td> <td id="new_id-2981"> </td> <td id="new_id-2982"> </td> <td id="new_id-2983"> </td> <td id="new_id-2984"> </td> <td id="new_id-2985"> </td> <td id="new_id-2986"> </td> <td id="new_id-2987"> </td> <td id="new_id-2988"> </td> <td id="new_id-2989"> </td> <td id="new_id-2990"> </td> <td id="new_id-2991"> </td> <td id="new_id-2992"> </td> <td id="new_id-2993"> </td> <td id="new_id-2994"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 52%;"> Assets: </td> <td id="new_id-2995" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-2996" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-2997" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-2998" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-2999" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3000" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3001" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3002" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3003" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3004" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3005" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3006" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3007" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3008" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3009" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3010" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-3011"> </td> <td id="new_id-3012"> </td> <td id="new_id-3013"> </td> <td id="new_id-3014"> </td> <td id="new_id-3015"> </td> <td id="new_id-3016"> </td> <td id="new_id-3017"> </td> <td id="new_id-3018"> </td> <td id="new_id-3019"> </td> <td id="new_id-3020"> </td> <td id="new_id-3021"> </td> <td id="new_id-3022"> </td> <td id="new_id-3023"> </td> <td id="new_id-3024"> </td> <td id="new_id-3025"> </td> <td id="new_id-3026"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Liabilities: </td> <td id="new_id-3027" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3028" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3029" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3030" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3031" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3032" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3033" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3034" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3035" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3036" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3037" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3038" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3039" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3040" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3041" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3042" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td id="new_id-3043"> </td> <td id="new_id-3044"> </td> <td id="new_id-3045"> </td> <td id="new_id-3046"> </td> <td id="new_id-3047"> </td> <td id="new_id-3048"> </td> <td id="new_id-3049"> </td> <td id="new_id-3050"> </td> <td id="new_id-3051"> </td> <td id="new_id-3052"> </td> <td id="new_id-3053"> </td> <td id="new_id-3054"> </td> <td id="new_id-3055"> </td> <td id="new_id-3056"> </td> <td id="new_id-3057"> </td> <td id="new_id-3058"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability at fair value as of September 30, 2021 </td> <td id="new_id-3059" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3060" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3061" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553,979</td> <td id="new_id-3062" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3063" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3064" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3065" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3066" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3067" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3068" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3069" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3070" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3071" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3072" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3073" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553,979</td> <td id="new_id-3074" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability warrants at fair value as of September 30, 2021 </td> <td id="new_id-3075" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3076" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3077" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">372,643</td> <td id="new_id-3078" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3079" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3080" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3081" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3082" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3083" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3084" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3085" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3086" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3087" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3088" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3089" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">372,643</td> <td id="new_id-3090" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability at fair value as of March 31, 2022 </td> <td id="new_id-3091" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3092" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3093" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3094" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3095" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3096" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3097" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3098" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3099" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3100" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3101" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3102" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3103" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3104" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td id="new_id-3105" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3106" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> Derivative Liability warrants at fair value as of March 31, 2022 </td> <td id="new_id-3107" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3108" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3109" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3110" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3111" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3112" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3113" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td id="new_id-3114" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3115" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3116" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3117" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td id="new_id-3118" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3119" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3120" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3121" style="width: 9%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3122" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

2553979

372643

2400203

597997

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3123" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3124" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Derivative Liability </td> <td id="new_id-3125" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-3126" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3127" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Derivative Liability Warrants </td> <td id="new_id-3128" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 62%;"> Balance as of September 30, 2021 </td> <td id="new_id-3129" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3130" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3131" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,553,979</td> <td id="new_id-3132" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3133" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3134" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3135" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">372,643</td> <td id="new_id-3136" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Extinguishment of derivatives </td> <td id="new_id-3137" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3138" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3139" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(96,205</td> <td id="new_id-3140" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> ) </td> <td id="new_id-3141" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3142" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3143" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td> <td id="new_id-3144" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Initial derivative liabilities </td> <td id="new_id-3145" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3146" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3147" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">134,384</td> <td id="new_id-3148" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3149" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3150" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3151" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td> <td id="new_id-3152" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Net (Gain)/Loss on change in fair value of derivative liability </td> <td id="new_id-3153" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3154" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3155" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(191,955</td> <td id="new_id-3156" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> ) </td> <td id="new_id-3157" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3158" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3159" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">225,354</td> <td id="new_id-3160" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Ending balance as of March 31, 2022 </td> <td id="new_id-3161" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3162" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3163" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,400,203</td> <td id="new_id-3164" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3165" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3166" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3167" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">597,997</td> <td id="new_id-3168" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

2553979

372643

-96205

134384

-191955

225354

2400203

597997

Recent Accounting Pronouncements In May 2021, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) 2021-04—Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options, to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU are effective for public and nonpublic entities for fiscal years beginning after December 15, 2021, and interim periods with fiscal years beginning after December 15, 2021. Early adoption is permitted, including adoption in an interim period. The Company has evaluated the impact of the adoption of ASU 2021-04, which had no effect on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

3. CAPITAL STOCK At March 31, 2022, the Company’s authorized stock consisted of 2,000,000,000 shares of common stock, with no par value. Effective August 25, 2020, we filed articles of amendment to our articles of incorporation with the Colorado Secretary of State to effectuate a 1-for-1,000 reverse stock split of the Company’s outstanding shares of common stock. The Company is also authorized to issue 50,000,000 shares of preferred stock with a par value of $0.01 per share. The rights, preferences and privileges of the holders of the preferred stock are determined by the Board of Directors prior to issuance of such shares. Preferred Stock As of March 31, 2022 the Company had 600 shares of issued and outstanding Series B Preferred Stock following the conversion of 5,000 shares of Series A Preferred Stock and redemption of 24,400 shares of Series B Preferred Stock. The Series A shares were originally issued in consideration for the contribution of services by Tom Djokovich, the former President and Chief Executive Officer, to the Company valued at fifty dollars, which the Board deemed full and fair consideration. Because of such issuance, Mr. Djokovich had the ability to influence and determine stockholder votes. On March 18, 2020, the Company, Mr. Djokovich, and TN3, LLC, a Wyoming limited liability company owned by Daniel G. Martin (“TN3”), entered into a Stock Purchase Agreement (the “Agreement”). Pursuant to the Agreement, Mr. Djokovich agreed to sell his 5,000 shares of Series A Preferred Stock to TN3 in a private sale for cash. The holder of the Series A Preferred Stock could cast votes equal to not less than 60% of the total outstanding voting power of the Company on all matters voted on by the shareholders of the Company. On September 4, 2020, the Company issued 25,000 shares of unregistered Series B Convertible Preferred stock, $0.01 par value per share to TN3 in exchange for the redemption of 5,000 shares of Series A preferred stock. On March 14, 2022 the Novaccess redeemed 24,400 shares of the Company’s Series B Convertible Preferred Stock held by TN3. Irvin Consulting LLC, a company owned by Dwain Irvin, the CEO of NovAccess, purchased remaining 600 shares (please refer to Note 12 for more details). Each share of outstanding Series B Preferred Stock entitles the holder to cast 40,000 votes. Each share of Series B Preferred Stock is convertible at the option of the holder into 10,000 common shares. In the event of any voluntary or involuntary liquidation, dissolution, or winding-up of the Corporation, the holders of shares of Series B Preferred Stock shall be paid out based on an as converted basis. Dividend for Series B Preferred Stock shall be declared on an as converted basis. Common Stock Effective August 25, 2020, we filed articles of amendment to our articles of incorporation with the Colorado Secretary of State to effectuate a 1-for-1,000 reverse stock split of the Company’s outstanding shares of common stock. During the six months ended March 31, 2022, the Company issued 3,119,643 shares of common stock. 1,502,670 shares were issued to TN3 as part of the transaction to redeem 24,400 shares of Series B Preferred Stock, 265,973 shares were issued to various vendors for services provided; 791,000 shares were issued in relation to stock subscriptions; 300,000 shares were issued as a commitment fee on a promissory note payable; 250,000 shares were issued as repayment of bridge loans (please refer to Note 4 for more details); and 10,000 shares were issued to related parties (please refer to Note 12 for more details). During the six months ended March 31, 2021, the Company issued 11,252,850 shares of common stock. For an expense of $145,941 based on the closing market value on grant date 311,945 shares were issued to various vendors for services provided; 1,440,905 shares were issued in relation to stock subscriptions for net proceeds of $295,000; and 9,500,000 shares were issued to related parties for services and expense at $936,000 based upon the closing market value on grant date.

2000000000

50000000

0.01

600

5000

24400

5000

25000

0.01

24400

600

Each share of outstanding Series B Preferred Stock entitles the holder to cast 40,000 votes.

Each share of Series B Preferred Stock is convertible at the option of the holder into 10,000 common shares

1-for-1,000

3119643

1502670

24400

265973

791000

300000

250000

10000

11252850

145941

311945

1440905

295000

9500000

936000

4. CONVERTIBLE PROMISSORY NOTES As of March 31, 2022, the outstanding convertible promissory notes are summarized as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 81%;"> Convertible Promissory Notes </td> <td id="new_id-3169" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3170" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3171" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">165,880</td> <td id="new_id-3172" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Less current portion </td> <td id="new_id-3173" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3174" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3175" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3176" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Total long-term liabilities </td> <td id="new_id-3177" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3178" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3179" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">165,880</td> <td id="new_id-3180" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table> Maturities of long-term debt for the next four years are as follows: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:50%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:bottom;width:65.8%;"> Year Ending </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> </tr> <tr> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"> September 30, </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="vertical-align:bottom;width:auto;"> 2023 </td> <td style="vertical-align:bottom;width:0.9%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.9%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:24.1%;"> 165,880 </td> <td style="vertical-align:bottom;width:0.9%;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:0.9%;"> </td> <td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.9%;"> $ </td> <td style="border-bottom:double 3px #000000;vertical-align:bottom;width:24.1%;"> 165,880 </td> <td style="vertical-align:bottom;width:0.9%;"> </td> </tr> </table> On November 20, 2014, the Company issued a 10% unsecured convertible promissory note (the “2014 Note”) for the principal sum of up to $400,000 plus accrued interest on any advanced principal funds. The 2014 Note matures eighteen months from each advance. The 2014 Note may be converted by the lender into shares of common stock of the Company at the lesser of $12.50 per share or (b) fifty percent (50%) of the lowest trade prices following issuance of the 2014 Note or (c) the lowest effective price per share granted to any person or entity. On November 20, 2014, the lender advanced $50,000 to the Company under the 2014 Note at inception. On various dates from February 18, 2015 through September 30, 2016, the lender advanced an additional $350,000 under the 2014 Note. During the period ended September 30, 2021, the Company and lender agreed to extend the maturity date for the outstanding balance to June 30, 2023. As of March 31, 2022, there remains an aggregate outstanding principal balance of $50,880. On May 10, 2017, the Company issued a 10% unsecured convertible promissory note (the “2017 Note”) for the principal sum of up to $150,000 plus accrued interest on any advanced principal funds. The lender may pay additional consideration at the lender’s discretion. The Company received a tranche in the amount of $25,000 upon execution of the 2017 Note. On various dates, the Company received additional tranches in the aggregate sum of $90,000. The 2017 Note matured twelve months from each tranche. Within thirty (30) days prior to the maturity date, the lender may extend the maturity date to sixty (60) months. During the period ended September 30, 2021, the Company and lender agreed to extend the maturity date for the outstanding balance to June 30, 2023. The 2017 Note may be converted by the lender into shares of common stock of the Company at the lesser of $10 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity. As of March 31, 2022, the balance remaining on the May Note was $115,000. On June 2, 2021, the Company issued a 12% unsecured convertible promissory note (the “June Note”) for the principal sum of $55,500 plus accrued interest. The June Note was to mature on June 2, 2022. The June Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion. On October 5, 2021 the Company paid the balance of this note to the lender including accrued interest and prepayment settlement fee of $17,520. The Company recorded amortization of debt discount of $36,493 and amortization of debt issuance costs of $1,458, both of which were recognized as interest expense during the six months ended March 31, 2022. The Company also recognized a gain of $59,915 on the extinguishment of this convertible note during the six months ended March 31, 2022. As of March 31, 2022, the balance of the June Note was $0. On July 6, 2021, the Company issued a 12% unsecured convertible promissory note (the “July Note”) for the principal sum of $38,750 plus accrued interest. The July Note was to mature on July 6, 2022. The July Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion. On December 30, 2021 the Company paid the balance of this note to the lender including accrued interest and prepayment settlement fee of $16,936. The Company recorded amortization of debt discount of $29,620 and amortization of debt issuance costs of $1,996, both of which were recognized as interest expense during the six months ended March 31, 2022. The Company also recognized a gain of $36,289 on the extinguishment of this convertible note during the six months ended March 31, 2022. As of March 31, 2022, the balance of the June Note was $0. On August 20, 2021, the Company issued a 10% unsecured promissory note (the “August Note”) for the principal sum of $500,000 plus accrued interest. The August Note was to mature on February 20, 2022, unless extended for up to an additional six months. The August Note may be converted, only following an event of default, and therefore not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period. In February 2022 the Company extended the term of the August note for an additional six months. The extended maturity date is February 20, 2023. The Company recorded amortization of debt discount of $391,319 related to derivative portion of the August Note, amortization of debt issuance costs of $75,000, and $34,181 amortization of debt discount representing commitment fee all of which were recognized as interest expense during the six months ended March 31, 2022 in the consolidated statement of operations for the six months ended March 31, 2022. As of March 31, 2022, the balance of the August Note was $500,000. On February 16, 2022, the Company issued a 10% unsecured promissory note (the “February note”) for the principal sum of $250,000 plus accrued interest. The February Note matures on August 15, 2022, unless extended for up to an additional six months. The February Note may be converted, only following an event of default, and therefore is not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period. The Company recorded amortization of debt discount of $32,849 related to derivative portion of the February Note and amortization of debt issuance costs of $9,250, and $19,654 amortization of debt discount representing commitment fee, all of which were recognized as interest expense during the three months ended March 31, 2022, in the consolidated statement of operations for the three months ended March 31, 2022. As of March 31, 2022, the balance of the August Note was $250,000, which is the total of initial debt discount of $134,384, initial debt issuance costs of $37,000 and initial debt discount representing a commitment fee of $78,616. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The notes have no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the notes under paragraph 815-15-25-4, whereby there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the notes in their entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations based upon the Binomial lattice model calculation. The convertible notes issued and described in this Note 4 above, do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as a derivative liability to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. We record the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the notes. At March 31, 2022, the fair value of the derivative liability was $2,400,203. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation of the derivatives are as follows: <table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto; height: 68px;"> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Risk free interest rate </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> Between 0.73%and 2.28% </td> </tr> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Stock volatility factor </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> Between 144.0% and 336.0% </td> </tr> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Months to Maturity </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> 0 - 5 years </td> </tr> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Expected dividend yield </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> None </td> </tr> </table>

As of March 31, 2022, the outstanding convertible promissory notes are summarized as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 81%;"> Convertible Promissory Notes </td> <td id="new_id-3169" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3170" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3171" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">165,880</td> <td id="new_id-3172" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Less current portion </td> <td id="new_id-3173" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3174" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3175" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td id="new_id-3176" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Total long-term liabilities </td> <td id="new_id-3177" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3178" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3179" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">165,880</td> <td id="new_id-3180" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

165880

Maturities of long-term debt for the next four years are as follows: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:50%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:bottom;width:65.8%;"> Year Ending </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> </tr> <tr> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"> September 30, </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:auto;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="vertical-align:bottom;width:auto;"> 2023 </td> <td style="vertical-align:bottom;width:0.9%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.9%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:24.1%;"> 165,880 </td> <td style="vertical-align:bottom;width:0.9%;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="vertical-align:bottom;width:auto;"> </td> <td style="vertical-align:bottom;width:0.9%;"> </td> <td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.9%;"> $ </td> <td style="border-bottom:double 3px #000000;vertical-align:bottom;width:24.1%;"> 165,880 </td> <td style="vertical-align:bottom;width:0.9%;"> </td> </tr> </table>

165880

0.10

400000

P18M

The 2014 Note may be converted by the lender into shares of common stock of the Company at the lesser of $12.50 per share or (b) fifty percent (50%) of the lowest trade prices following issuance of the 2014 Note or (c) the lowest effective price per share granted to any person or entity

50000

350000

50880

0.10

150000

25000

90000

The 2017 Note matured twelve months from each tranche. Within thirty (30) days prior to the maturity date, the lender may extend the maturity date to sixty (60) months

The 2017 Note may be converted by the lender into shares of common stock of the Company at the lesser of $10 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity

115000

0.12

55500

The June Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion.

17520

36493

1458

59915

0.12

38750

The July Note could be converted by the lender into shares of common stock of the Company at sixty-one percent (61%) of the lowest trade price of common stock recorded during the fifteen (15) trading days prior to conversion.

16936

29620

1996

36289

0.10

500000

converted, only following an event of default, and therefore not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period

391319

75000

34181

500000

0.10

250000

converted, only following an event of default, and therefore is not included in summary of convertibles note, by the lender into shares of common stock of the Company at the lesser of 90% (representing a 10% discount) multiplied by the lowest trading price during the previous twenty (20) trading day period ending on the issuance date, or during the previous twenty (20) trading day period

32849

9250

19654

250000

134384

37000

78616

2400203

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation of the derivatives are as follows: <table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto; height: 68px;"> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Risk free interest rate </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> Between 0.73%and 2.28% </td> </tr> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Stock volatility factor </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> Between 144.0% and 336.0% </td> </tr> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Months to Maturity </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> 0 - 5 years </td> </tr> <tr style="height: 17px;"> <td style="vertical-align: bottom; width: 23.1%; height: 17px;"> Expected dividend yield </td> <td style="vertical-align: bottom; width: 2.4%; height: 17px;"> </td> <td style="vertical-align: bottom; width: 20.9%; height: 17px;"> None </td> </tr> </table>

0.0073

0.0228

1.44

3.36

5. CONVERTIBLE LOAN PAYABLE As of March 31, 2016, Company issued an unsecured Convertible Promissory Note (the “Note”) in the amount of $12,000 to a former Board member (the “Holder”) in exchange for retention as a director during the fiscal year ending September 30, 2014. The Note can be converted into shares of common stock by the Holder for $4.50 per share. The Note matured on October 1, 2015, and bore a one-time interest charge of $1,200 which was applied to the principal on October 1, 2014. So long as any shares issuable under a conversion are subject to transfer and sale restrictions imposed pursuant to SEC Rule 144 of the Rules promulgated under the Securities Act of 1933, the Company shall, upon written request by Holder, file Form S-8, if applicable, with the U.S. Securities and Exchange commission to register the issued.

12000

4.5

1200

6. WARRANTS On August 20, 2021, for value received in connection with the issuance of the August Note (see note 4 for more details), the Company issued 1,000,000 warrants to the lender with an exercise price of $1.50 per share with a five-year exercise period. On February 16, 2022, for value received in connection with the issuance of the February Note (see note 4 for more details), the Company issued 500,000 warrants to the lender with an exercise price of $1.50 per share with a five-year exercise period. At March 31, 2022, and September 30, 2021, the fair value of the derivative liability warrants was $597,997 and $372,643, respectively. For the purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation of the derivatives are as follows: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:bottom;width:23.2%;"> Risk free interest rate </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> 2.42% </td> </tr> <tr> <td style="vertical-align:bottom;width:23.2%;"> Stock volatility factor </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> Between 140% and 145% </td> </tr> <tr> <td style="vertical-align:bottom;width:23.2%;"> Months to Maturity </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> 5 years </td> </tr> <tr> <td style="vertical-align:bottom;width:23.2%;"> Expected dividend yield </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> None </td> </tr> </table>

1000000

1.5

500000

1.5

597997

372643

For the purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation of the derivatives are as follows: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:bottom;width:23.2%;"> Risk free interest rate </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> 2.42% </td> </tr> <tr> <td style="vertical-align:bottom;width:23.2%;"> Stock volatility factor </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> Between 140% and 145% </td> </tr> <tr> <td style="vertical-align:bottom;width:23.2%;"> Months to Maturity </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> 5 years </td> </tr> <tr> <td style="vertical-align:bottom;width:23.2%;"> Expected dividend yield </td> <td style="vertical-align:bottom;width:2.3%;"> </td> <td style="vertical-align:bottom;width:20.8%;"> None </td> </tr> </table>

0.0242

1.40

1.45

7. OPTIONS On June 2, 2020, the Company issued 2,000,000 options to purchase common stock at an exercise price of $0.01 per share (adjusted for the August 2020 stock split). These options will be exercisable on a cashless basis for a period of ten years from August 25, 2020. The purpose of the options is to compensate our directors for serving on the board without compensation in fiscal 2019. It is difficult to assess the value of the options given the highly limited trading in our common stock, the fact that the options shares have not been and are not expected to be registered for resale and will be restricted, and the speculative nature of the Company’s future business plans. However, we estimated the value of the services provided by each of our directors during 2019 and believe that the value of the options to be issued to each of our resigning directors approximates that amount. At March 31, 2022, the weighted average remaining contractual life of options outstanding: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="10" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:23.6%;"> March 31, 2022 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Weighted </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Average </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Remaining </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Exercisable </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Options </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Options </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Contractual </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Prices </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Outstanding </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Exercisable </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Life (years) </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> $ </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.7%;"> 0.01 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.2%;"> 2,000,000 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.2%;"> 2,000,000 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.2%;"> 8.41 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> </table>

2000000

0.01

P10Y

At March 31, 2022, the weighted average remaining contractual life of options outstanding: <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="10" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:23.6%;"> March 31, 2022 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Weighted </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Average </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.7%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:10.2%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Remaining </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Exercisable </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Options </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Options </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="vertical-align:bottom;width:0.5%;"> Contractual </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Prices </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Outstanding </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Exercisable </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> Life (years) </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> $ </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.7%;"> 0.01 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.2%;"> 2,000,000 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.2%;"> 2,000,000 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;"> </td> <td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.2%;"> 8.41 </td> <td style="vertical-align:bottom;width:0.5%;"> </td> </tr> </table>

0.01

2000000

P8Y4M28D

8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable and accrued liabilities consisted of the following at March 31, 2022 and September 30, 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3181" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3182" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 03/31/2022 </td> <td id="new_id-3183" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-3184" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3185" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 9/30/2021 </td> <td id="new_id-3186" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 62%;"> Trade accounts payable </td> <td id="new_id-3187" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3188" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3189" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">161,922</td> <td id="new_id-3190" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3191" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3192" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3193" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">143,074</td> <td id="new_id-3194" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Credit cards payable </td> <td id="new_id-3195" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3196" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3197" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">66,894</td> <td id="new_id-3198" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3199" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3200" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3201" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">66,894</td> <td id="new_id-3202" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued liabilities and interest on notes payable </td> <td id="new_id-3203" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3204" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3205" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">105,783</td> <td id="new_id-3206" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3207" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3208" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3209" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">356,683</td> <td id="new_id-3210" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued payroll </td> <td id="new_id-3211" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3212" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3213" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">11,268</td> <td id="new_id-3214" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3215" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3216" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3217" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10,712</td> <td id="new_id-3218" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred compensation </td> <td id="new_id-3219" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3220" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3221" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">270,433</td> <td id="new_id-3222" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3223" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3224" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3225" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">201,383</td> <td id="new_id-3226" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> License fees payable </td> <td id="new_id-3227" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3228" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3229" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">36,912</td> <td id="new_id-3230" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3231" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3232" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3233" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,402</td> <td id="new_id-3234" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3235" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3236" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-3237" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">653,212</td> <td id="new_id-3238" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3239" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3240" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-3241" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">819,148</td> <td id="new_id-3242" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

Accounts payable and accrued liabilities consisted of the following at March 31, 2022 and September 30, 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3181" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3182" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 03/31/2022 </td> <td id="new_id-3183" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-3184" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3185" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 9/30/2021 </td> <td id="new_id-3186" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 62%;"> Trade accounts payable </td> <td id="new_id-3187" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3188" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3189" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">161,922</td> <td id="new_id-3190" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3191" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3192" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3193" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">143,074</td> <td id="new_id-3194" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Credit cards payable </td> <td id="new_id-3195" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3196" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3197" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">66,894</td> <td id="new_id-3198" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3199" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3200" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3201" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">66,894</td> <td id="new_id-3202" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued liabilities and interest on notes payable </td> <td id="new_id-3203" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3204" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3205" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">105,783</td> <td id="new_id-3206" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3207" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3208" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3209" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">356,683</td> <td id="new_id-3210" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued payroll </td> <td id="new_id-3211" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3212" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3213" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">11,268</td> <td id="new_id-3214" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3215" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3216" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3217" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10,712</td> <td id="new_id-3218" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred compensation </td> <td id="new_id-3219" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3220" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3221" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">270,433</td> <td id="new_id-3222" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3223" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3224" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3225" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">201,383</td> <td id="new_id-3226" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> License fees payable </td> <td id="new_id-3227" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3228" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3229" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">36,912</td> <td id="new_id-3230" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3231" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3232" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3233" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,402</td> <td id="new_id-3234" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3235" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3236" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-3237" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">653,212</td> <td id="new_id-3238" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3239" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-3240" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td id="new_id-3241" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">819,148</td> <td id="new_id-3242" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>

161922

143074

66894

105783

356683

11268

10712

270433

201383

36912

40402

653212

819148

9. BRIDGE LOANS PAYABLE Related Parties In December 2021, the Company’s CEO and CFO each advanced funds to the Company for operating expenses in the total amount of $50,000. The notes were payable on demand with a five business day written notice and bear interest at a rate of 10% per annum. The Company could prepay all or any part of the balance owed without penalty. In the event of the default, the notes were to bear additional interest at a rate of 12% per annum. On January 25, 2022 the Company issued 125,000 shares of its common stock in settlement of a bridge loan to the Company’s CFO and recognized a loss on extinguishment of debt in the amount of $17,313. Any potential gain would not have been recognized on extinguishment of this loan due to the nature of the relationship between the parties. The company recognized and paid interest expense in the amount of $237 to our CFO during the period ended March 31, 2022. During the period ended March 31, 2022 the Company made payments to our CEO in the total amount of $20,938, of which $18,616 were used to purchase 600 shares of Serie B Preferred stock, and $2,316 were related to reimbursement of expenses. The company recognized and capitalized into the principle of the loan interest expense of $546. As of March 31, 2022, the balance on the bridge loan payable to our CEO was $4,068. No balance was outstanding on the notes payable to our CFO. Service Provider In December 2021, one of the Company’s service providers advanced funds to the Company for operating expenses in the total amount of $25,000. On February 14, 2022 the Company issued 125,000 shares of its common stock to the service provider in settlement of the note payable. The Company recognized a loss on extinguishment of debt in the amount of $37,500. During the period ended March 31, 2022 the Company recognized and paid interest expense of $226 in relation to this loan. No balance was outstanding on the note payable to our service provider as of March 31, 2022.

0.10

0.12

125000

-17313

237

20938

18616

600

2316

546

4068

25000

125000

-37500

226

10. DUE TO RELATED PARTY During the periods prior to the period ended March 31, 2022, Innovest Global, Inc. (Innovest) advanced funds to the Company for operating expenses in the amount of $86,073. As of March 31, 2022, the amount has not been reimbursed to Innovest. Our former Chairman Daniel Martin was the CEO of Innovest when the funds were advanced. Imputed interest is calculated on an annual basis at the market rate and is estimated to equal $516 as of March 31, 2022.

86073

516

11. COMMITMENTS AND CONTINGENCIES There are no material pending legal proceedings to which we are a party to, nor are there any such proceedings known to be contemplated by governmental authorities. None of our directors, officers, or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

12. RELATED PARTY TRANSACTIONS On September 4, 2020, the Company entered into a management services agreement (the “Agreement”) with TN3, LLC. Pursuant to the Agreement, TN3 was to provide NovAccess with office space in Chesterland, Ohio and management, administrative, marketing, bookkeeping and IT services for a fee of $30,000 a month. The initial term of the Agreement was three years, with subsequent one-year renewals. During the three months ended March 31, 2022, the Company entered into a transaction with TN3 to redeem its shares of the Company’s Series B Convertible preferred stock (please refer to more details below). This transaction terminated the Agreement, including satisfaction for all services provided and any amounts outstanding. As of March 31, 2022 there was zero balance reported as the outstanding payable amount in relation to the Agreement. On October 4, 2021, the Company issued 10,000 shares of common stock to Neil J. Laird to compensate him for serving as our chief financial officer. The stock-based compensation expense in the amount of $8,000 was reported on the Company’s financial statements for the six months ended March 31, 2022. On January 31, 2022, the Company entered into a preferred stock redemption agreement (the “redemption agreement”) with Daniel G. Martin, at the time our sole board member and chairman, TN3, LLC, a company owned by Mr. Martin, Dwain K. Morris-Irvin, our chief executive officer, and Irvin Consulting, LLC, a company owned by Dr. Irvin. TN3 owned 25,000 shares of our Series B convertible preferred stock. Pursuant to the redemption agreement, on March 14, 2022, NovAccess redeemed 24,400 of the preferred shares and Irvin Consulting purchased 600 of the preferred shares from TN3. In connection with the redemption, we issued to TN3 1,502,670 shares of unregistered common stock. To redeem the preferred shares, the Company is to pay TN3 a total of $250,000 over a period of ten months, with payment accelerated if the company raises significant capital. The company paid $50,000 to TN3 in relation to this transaction during the three months ended March 31, 2022. As of March 31, 2022 the balance owed to TN3 on this transaction is $200,000. Upon completion of the redemption, Mr. Martin resigned from the NovAccess board of directors and was replaced by Dr. Irvin and John Cassarini. On March 18, 2022, the board of directors of NovAccess voted to expand the size of the company’s board to three members and appointed Jason M. Anderson to the board to fill the resulting vacancy.

30000 P3Y

10000

8000

25000

24400

600

1502670

250000

50000

200000

13. SUBSEQUENT EVENTS Management has evaluated subsequent events as of May 13, 2022, the date the consolidated financial statements were available to be issued according to the requirements of ASC topic 855. On May 5, 2022, NovAccess entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of $1.0 million (the “note”) to AJB pursuant to the SPA. The loan closed and was funded on May 9, 2022. NovAccess used $500,000 of the proceeds of the loan to repay AJB’s August 20, 2021 loan and will use the remaining loan proceeds for general working capital purposes. The note has an original issuance discount of 10% of the principal and bears interest at 12% a year. The note is due on November 5, 2022, but may be extended for six months by NovAccess, at which time the rate will increase to 15%. NovAccess must repay the note with the proceeds of any loan or capital raise exceeding $5.0 million and may otherwise prepay the note at any time without penalty. Under the terms of the note, NovAccess may not sell a significant portion of its assets without the approval of AJB, may not issue additional debt that is not subordinate to AJB, must comply with the company’s reporting requirements under the Securities Exchange Act of 1934, and must maintain the listing of the company’s common stock on the OTC Market or other exchange, among other restrictions and requirements. NovAccess’ failure to make required payments under the note or to comply with any of these covenants, among other matters, would constitute an event of default. Upon an event of default under the SPA or note, the note will bear interest at 18%, AJB may immediately accelerate the note due date, AJB may convert the amount outstanding under the note into shares of NovAccess common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies. NovAccess provided customary representations and covenants to AJB in the SPA. NovAccess’ breach of any representation or failure to comply with the covenants would constitute an event of default. Also pursuant to the SPA, NovAccess paid AJB a commitment fee of 875,000 unregistered shares of the company’s common stock (the “commitment fee shares”). If, after May 5, 2023 and before May 5, 2025, AJB is unable to sell the commitment fee shares for $700,000, then AJB may require NovAccess to issue additional shares or pay cash in the amount of the shortfall. However, if NovAccess pays the note off before November 5, 2022, then the company may redeem 437,500 of the commitment shares for one dollar. Pursuant to the SPA, NovAccess also issued to AJB a common stock purchase warrant (the “warrant”) to purchase 1.0 million shares of the company’s common stock for $0.01 a share. The warrant expires on May 5, 2027. NovAccess also entered into a security agreement with AJB (the “security agreement”) pursuant to which NovAccess granted to AJB a security interest in all of the company’s assets, including the equity of StemVax, LLC, securing NovAccess’ obligations under the SPA, note and warrant. In addition, NovAccess entered into a registration rights agreement with AJB (the “registration agreement”) pursuant to which NovAccess agreed to file with the Securities and Exchange Commission a Form S-1 by August 3, 2022 to register for resale the commitment fee shares and the shares issuable upon exercise of the warrant.

500000

0.10

0.12

The note is due on November 5, 2022, but may be extended for six months by NovAccess

0.15

NovAccess must repay the note with the proceeds of any loan or capital raise exceeding $5.0 million and may otherwise prepay the note at any time without penalty

0.18

Also pursuant to the SPA, NovAccess paid AJB a commitment fee of 875,000 unregistered shares of the company’s common stock (the “commitment fee shares”). If, after May 5, 2023 and before May 5, 2025, AJB is unable to sell the commitment fee shares for $700,000, then AJB may require NovAccess to issue additional shares or pay cash in the amount of the shortfall. However, if NovAccess pays the note off before November 5, 2022, then the company may redeem 437,500 of the commitment shares for one dollar. Pursuant to the SPA, NovAccess also issued to AJB a common stock purchase warrant (the “warrant”) to purchase 1.0 million shares of the company’s common stock for $0.01 a share. The warrant expires on May 5, 2027. NovAccess also entered into a security agreement with AJB (the “security agreement”) pursuant to which NovAccess granted to AJB a security interest in all of the company’s assets, including the equity of StemVax, LLC, securing NovAccess’ obligations under the SPA, note and warrant. In addition, NovAccess entered into a registration rights agreement with AJB (the “registration agreement”) pursuant to which NovAccess agreed to file with the Securities and Exchange Commission a Form S-1 by August 3, 2022 to register for resale the commitment fee shares and the shares issuable upon exercise of the warrant.

NONE

false --09-30 Q2 2022 0001039466

EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
!@ &0 M @($$T >&PO=V]R:W-H965T&UL4$L! A0#% @ :96M5,AB;J#N @ 5@@ !D M ("!C=4 'AL+W=O&PO M=V]R:W-H965T !X;"]W;W)K&UL4$L! A0#% @ :96M5 Q>L[[H P 1! !D ("! MO. 'AL+W=O&PO=V]R:W-H965T/T !;0V]N=&5N=%]4 ?>7!E&UL4$L%!@ T #0 (PX ,+V $! end XML 56 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 58 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 133 226 1 false 42 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.xsunx.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.xsunx.com/role/ConsolidatedBalanceSheet CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) Sheet http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals CONSOLIDATED BALANCE SHEETS (Parentheticals) Statements 3 false false R4.htm 003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.xsunx.com/role/ConsolidatedIncomeStatement CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 004 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.xsunx.com/role/ShareholdersEquityType2or3 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.xsunx.com/role/ConsolidatedCashFlow CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 006 - Disclosure - ORGANIZATION AND LINE OF BUSINESS Sheet http://www.xsunx.com/role/ORGANIZATIONANDLINEOFBUSINESS ORGANIZATION AND LINE OF BUSINESS Notes 7 false false R8.htm 007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 008 - Disclosure - CAPITAL STOCK Sheet http://www.xsunx.com/role/CAPITALSTOCK CAPITAL STOCK Notes 9 false false R10.htm 009 - Disclosure - CONVERTIBLE PROMISSORY NOTES Notes http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTES CONVERTIBLE PROMISSORY NOTES Notes 10 false false R11.htm 010 - Disclosure - CONVERTIBLE LOAN PAYABLE Sheet http://www.xsunx.com/role/CONVERTIBLELOANPAYABLE CONVERTIBLE LOAN PAYABLE Notes 11 false false R12.htm 011 - Disclosure - WARRANTS Sheet http://www.xsunx.com/role/WARRANTS WARRANTS Notes 12 false false R13.htm 012 - Disclosure - OPTIONS Sheet http://www.xsunx.com/role/OPTIONS OPTIONS Notes 13 false false R14.htm 013 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Sheet http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Notes 14 false false R15.htm 014 - Disclosure - BRIDGE LOANS PAYABLE - RELATED PARTIES Sheet http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIES BRIDGE LOANS PAYABLE - RELATED PARTIES Notes 15 false false R16.htm 015 - Disclosure - DUE TO RELATED PARTY Sheet http://www.xsunx.com/role/DUETORELATEDPARTY DUE TO RELATED PARTY Notes 16 false false R17.htm 016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.xsunx.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 017 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 018 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.xsunx.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 19 false false R20.htm 019 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.xsunx.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 20 false false R21.htm 020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 21 false false R22.htm 021 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Tables) Notes http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables CONVERTIBLE PROMISSORY NOTES (Tables) Tables http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTES 22 false false R23.htm 022 - Disclosure - WARRANTS (Tables) Sheet http://www.xsunx.com/role/WARRANTSTables WARRANTS (Tables) Tables http://www.xsunx.com/role/WARRANTS 23 false false R24.htm 023 - Disclosure - OPTIONS (Tables) Sheet http://www.xsunx.com/role/OPTIONSTables OPTIONS (Tables) Tables http://www.xsunx.com/role/OPTIONS 24 false false R25.htm 024 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Sheet http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Tables http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES 25 false false R26.htm 025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment Sheet http://www.xsunx.com/role/PropertyPlantandEquipmentTable SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment Details http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 26 false false R27.htm 026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted Sheet http://www.xsunx.com/role/ScheduleofEarningsPerShareBasicandDilutedTable SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted Details http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 27 false false R28.htm 027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Sheet http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Details http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 28 false false R29.htm 028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation Sheet http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation Details http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 29 false false R30.htm 029 - Disclosure - CAPITAL STOCK (Details) Sheet http://www.xsunx.com/role/CAPITALSTOCKDetails CAPITAL STOCK (Details) Details http://www.xsunx.com/role/CAPITALSTOCK 30 false false R31.htm 030 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) Notes http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails CONVERTIBLE PROMISSORY NOTES (Details) Details http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables 31 false false R32.htm 031 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Debt Notes http://www.xsunx.com/role/ScheduleofDebtTable CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Debt Details http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables 32 false false R33.htm 032 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Maturities of Long-term Debt Notes http://www.xsunx.com/role/ScheduleofMaturitiesofLongtermDebtTable CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Maturities of Long-term Debt Details http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables 33 false false R34.htm 033 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques Notes http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable CONVERTIBLE PROMISSORY NOTES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques Details http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables 34 false false R35.htm 034 - Disclosure - CONVERTIBLE LOAN PAYABLE (Details) Sheet http://www.xsunx.com/role/CONVERTIBLELOANPAYABLEDetails CONVERTIBLE LOAN PAYABLE (Details) Details http://www.xsunx.com/role/CONVERTIBLELOANPAYABLE 35 false false R36.htm 035 - Disclosure - WARRANTS (Details) Sheet http://www.xsunx.com/role/WARRANTSDetails WARRANTS (Details) Details http://www.xsunx.com/role/WARRANTSTables 36 false false R37.htm 036 - Disclosure - WARRANTS (Details) - Fair Value Measurement Inputs and Valuation Techniques Sheet http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable WARRANTS (Details) - Fair Value Measurement Inputs and Valuation Techniques Details http://www.xsunx.com/role/WARRANTSTables 37 false false R38.htm 037 - Disclosure - OPTIONS (Details) Sheet http://www.xsunx.com/role/OPTIONSDetails OPTIONS (Details) Details http://www.xsunx.com/role/OPTIONSTables 38 false false R39.htm 038 - Disclosure - OPTIONS (Details) - Share-based Payment Arrangement, Option, Exercise Price Range Sheet http://www.xsunx.com/role/SharebasedPaymentArrangementOptionExercisePriceRangeTable OPTIONS (Details) - Share-based Payment Arrangement, Option, Exercise Price Range Details http://www.xsunx.com/role/OPTIONSTables 39 false false R40.htm 039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities Sheet http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities Details http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables 40 false false R41.htm 040 - Disclosure - BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) Sheet http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) Details http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIES 41 false false R42.htm 041 - Disclosure - DUE TO RELATED PARTY (Details) Sheet http://www.xsunx.com/role/DUETORELATEDPARTYDetails DUE TO RELATED PARTY (Details) Details http://www.xsunx.com/role/DUETORELATEDPARTY 42 false false R43.htm 042 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONS 43 false false R44.htm 043 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://www.xsunx.com/role/SUBSEQUENTEVENTS 44 false false All Reports Book All Reports novaccess20220331_10q.htm ex_372769.htm ex_372770.htm ex_372771.htm xsnx-20220331.xsd xsnx-20220331_cal.xml xsnx-20220331_def.xml xsnx-20220331_lab.xml xsnx-20220331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 61 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "novaccess20220331_10q.htm": { "axisCustom": 0, "axisStandard": 14, "contextCount": 133, "dts": { "calculationLink": { "local": [ "xsnx-20220331_cal.xml" ] }, "definitionLink": { "local": [ "xsnx-20220331_def.xml" ] }, "inline": { "local": [ "novaccess20220331_10q.htm" ] }, "labelLink": { "local": [ "xsnx-20220331_lab.xml" ] }, "presentationLink": { "local": [ "xsnx-20220331_pre.xml" ] }, "schema": { "local": [ "xsnx-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 362, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 1, "http://xbrl.sec.gov/dei/2022": 6, "total": 7 }, "keyCustom": 9, "keyStandard": 217, "memberCustom": 13, "memberStandard": 26, "nsprefix": "xsnx", "nsuri": "http://www.xsunx.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.xsunx.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - CONVERTIBLE PROMISSORY NOTES", "role": "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTES", "shortName": "CONVERTIBLE PROMISSORY NOTES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - CONVERTIBLE LOAN PAYABLE", "role": "http://www.xsunx.com/role/CONVERTIBLELOANPAYABLE", "shortName": "CONVERTIBLE LOAN PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - WARRANTS", "role": "http://www.xsunx.com/role/WARRANTS", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - OPTIONS", "role": "http://www.xsunx.com/role/OPTIONS", "shortName": "OPTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "role": "http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - BRIDGE LOANS PAYABLE - RELATED PARTIES", "role": "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIES", "shortName": "BRIDGE LOANS PAYABLE - RELATED PARTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - DUE TO RELATED PARTY", "role": "http://www.xsunx.com/role/DUETORELATEDPARTY", "shortName": "DUE TO RELATED PARTY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.xsunx.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.xsunx.com/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.xsunx.com/role/ConsolidatedBalanceSheet", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.xsunx.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Tables)", "role": "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables", "shortName": "CONVERTIBLE PROMISSORY NOTES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c106", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - WARRANTS (Tables)", "role": "http://www.xsunx.com/role/WARRANTSTables", "shortName": "WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c106", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - OPTIONS (Tables)", "role": "http://www.xsunx.com/role/OPTIONSTables", "shortName": "OPTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "role": "http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c44", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment", "role": "http://www.xsunx.com/role/PropertyPlantandEquipmentTable", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c44", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted", "role": "http://www.xsunx.com/role/ScheduleofEarningsPerShareBasicandDilutedTable", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis", "role": "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c50", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation", "role": "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c50", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)", "role": "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - CAPITAL STOCK (Details)", "role": "http://www.xsunx.com/role/CAPITALSTOCKDetails", "shortName": "CAPITAL STOCK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:ConversionOfStockSharesConverted1", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c100", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details)", "role": "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "shortName": "CONVERTIBLE PROMISSORY NOTES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c74", "decimals": "2", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Debt", "role": "http://www.xsunx.com/role/ScheduleofDebtTable", "shortName": "CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Debt", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:LongTermDebtCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Maturities of Long-term Debt", "role": "http://www.xsunx.com/role/ScheduleofMaturitiesofLongtermDebtTable", "shortName": "CONVERTIBLE PROMISSORY NOTES (Details) - Schedule of Maturities of Long-term Debt", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c99", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - CONVERTIBLE PROMISSORY NOTES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques", "role": "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable", "shortName": "CONVERTIBLE PROMISSORY NOTES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c99", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c100", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - CONVERTIBLE LOAN PAYABLE (Details)", "role": "http://www.xsunx.com/role/CONVERTIBLELOANPAYABLEDetails", "shortName": "CONVERTIBLE LOAN PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c100", "decimals": "2", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c104", "decimals": "0", "first": true, "lang": null, "name": "xsnx:ClassOfWarrantOrRightsGranted", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - WARRANTS (Details)", "role": "http://www.xsunx.com/role/WARRANTSDetails", "shortName": "WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c104", "decimals": "0", "first": true, "lang": null, "name": "xsnx:ClassOfWarrantOrRightsGranted", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c107", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - WARRANTS (Details) - Fair Value Measurement Inputs and Valuation Techniques", "role": "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "shortName": "WARRANTS (Details) - Fair Value Measurement Inputs and Valuation Techniques", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c107", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c112", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - OPTIONS (Details)", "role": "http://www.xsunx.com/role/OPTIONSDetails", "shortName": "OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c112", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - OPTIONS (Details) - Share-based Payment Arrangement, Option, Exercise Price Range", "role": "http://www.xsunx.com/role/SharebasedPaymentArrangementOptionExercisePriceRangeTable", "shortName": "OPTIONS (Details) - Share-based Payment Arrangement, Option, Exercise Price Range", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.xsunx.com/role/ConsolidatedIncomeStatement", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities", "role": "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c120", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - BRIDGE LOANS PAYABLE - RELATED PARTIES (Details)", "role": "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "shortName": "BRIDGE LOANS PAYABLE - RELATED PARTIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c120", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromRelatedPartyDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - DUE TO RELATED PARTY (Details)", "role": "http://www.xsunx.com/role/DUETORELATEDPARTYDetails", "shortName": "DUE TO RELATED PARTY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "xsnx:ImputedInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c125", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c130", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - SUBSEQUENT EVENTS (Details)", "role": "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c130", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "role": "http://www.xsunx.com/role/ShareholdersEquityType2or3", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.xsunx.com/role/ConsolidatedCashFlow", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - ORGANIZATION AND LINE OF BUSINESS", "role": "http://www.xsunx.com/role/ORGANIZATIONANDLINEOFBUSINESS", "shortName": "ORGANIZATION AND LINE OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - CAPITAL STOCK", "role": "http://www.xsunx.com/role/CAPITALSTOCK", "shortName": "CAPITAL STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "novaccess20220331_10q.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 42, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xsunx.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r242", "r335", "r336", "r338", "r401" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity [Member]" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/DUETORELATEDPARTYDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]", "terseLabel": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r173", "r210", "r244", "r245", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r388", "r389", "r402", "r403" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r173", "r210", "r244", "r245", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r388", "r389", "r402", "r403" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r146", "r150", "r151", "r152", "r153", "r173", "r210", "r234", "r244", "r245", "r273", "r274", "r275", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r388", "r389", "r402", "r403" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r146", "r150", "r151", "r152", "r153", "r173", "r210", "r234", "r244", "r245", "r273", "r274", "r275", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r388", "r389", "r402", "r403" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "totalLabel": "" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r27", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable, Other, Current", "terseLabel": "Credit cards payable" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r7", "r27" ], "calculation": { "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r6", "r32" ], "calculation": { "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Salaries, Current", "terseLabel": "Accrued payroll" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r88", "r89", "r90", "r282", "r283", "r284", "r302" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalPreferredStock": { "auth_ref": [ "r20" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholder in nonredeemable preferred stock-related transaction in excess of par value, value contributed to entity and value received from other stock-related transaction. Includes, but is not limited to, preferred stock redeemable solely at option of issuer. Excludes common stock.", "label": "Additional Paid in Capital, Preferred Stock", "terseLabel": "Paid in capital, preferred stock" } } }, "localname": "AdditionalPaidInCapitalPreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Stock compensation cost" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustment to reconcile net loss to net cash provided by (used in) operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AdvancesToAffiliate": { "auth_ref": [ "r396" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.", "label": "Advances to Affiliate", "terseLabel": "Employee Advances" } } }, "localname": "AdvancesToAffiliate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r57", "r70", "r193", "r327" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of Debt Discount (Premium)" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDeferredCharges": { "auth_ref": [ "r54" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of amortization of deferred charges applied against earnings during the period.", "label": "Amortization of Deferred Charges", "terseLabel": "Stock issued as commitment fee on promissory note payable" } } }, "localname": "AmortizationOfDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDeferredLoanOriginationFeesNet": { "auth_ref": [ "r70", "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.", "label": "Amortization of Deferred Loan Origination Fees, Net", "terseLabel": "Amortization of Deferred Loan Origination Fees, Net" } } }, "localname": "AmortizationOfDeferredLoanOriginationFeesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r53", "r70", "r193", "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of Debt Issuance Costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r70", "r193", "r203", "r204", "r329" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount and debt issuance costs recorded as interest expense" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r12", "r84", "r128", "r130", "r134", "r139", "r156", "r157", "r158", "r160", "r161", "r162", "r163", "r164", "r165", "r167", "r168", "r290", "r292", "r316", "r341", "r343", "r371", "r381" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r247", "r248", "r249", "r251", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Accounting, Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r11", "r72" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r64", "r72", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH, END OF PERIOD", "periodStartLabel": "CASH, BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r64", "r317" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r17", "r18", "r19", "r81", "r84", "r104", "r105", "r106", "r109", "r111", "r117", "r118", "r119", "r139", "r156", "r161", "r162", "r163", "r167", "r168", "r208", "r209", "r212", "r216", "r222", "r316", "r410" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/WARRANTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r147", "r148", "r149", "r154", "r398" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r88", "r89", "r302" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common Stock, No Par Value", "terseLabel": "Common stock, no par value (in Dollars per share)" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "verboseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, no par value; 2,000,000,000 authorized common shares 17,523,673 and 14,404,030 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r229", "r230", "r231" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Deferred Compensation" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r75", "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Conversion of Stock, Shares Converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r75", "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued", "terseLabel": "Preferred Stock Redemption (in Shares)", "verboseLabel": "Conversion of Stock, Shares Issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r15", "r373", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt, Current", "terseLabel": "Convertible promissory notes net of debt discount and debt issuance costs of $0 and $69,567, respectively" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r169", "r170", "r171", "r173", "r183", "r184", "r185", "r189", "r190", "r191", "r192", "r193", "r201", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r39" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible promissory notes" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible loan payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r75", "r77" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Debt Conversion, Converted Instrument, Shares Issued (in Shares)" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r80", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r187", "r194", "r195", "r196", "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r13", "r14", "r15", "r83", "r86", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r193", "r201", "r202", "r203", "r204", "r330", "r372", "r373", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r172", "r199" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt Instrument, Convertible, Conversion Price (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLELOANPAYABLEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "auth_ref": [ "r37", "r223", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for debt instrument.", "label": "Debt Instrument, Convertible, Terms of Conversion Feature", "terseLabel": "Debt Instrument, Convertible, Terms of Conversion Feature" } } }, "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r13", "r15", "r223", "r372", "r373", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt Instrument, Description", "terseLabel": "Debt Instrument, Description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r170", "r201", "r202", "r328", "r330", "r331" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount", "verboseLabel": "Debt Instrument, Face Amount (in Dollars)" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLELOANPAYABLEDetails", "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFee": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Description of a fee associated with the debt instrument, including a commitment fee on unborrowed portions of a lender's total contractual commitment.", "label": "Debt Instrument, Fee", "terseLabel": "Debt Instrument, Fee" } } }, "localname": "DebtInstrumentFee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r38" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Debt Instrument, Fee Amount", "terseLabel": "Debt Instrument, Fee Amount" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r35", "r171" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Debt Instrument, Maturity Date, Description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r39", "r83", "r86", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r193", "r201", "r202", "r203", "r204", "r330" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt Instrument, Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r183", "r327", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Convertible promissory notes, debt discount and debt issuance costs (in Dollars)" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r327", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt Instrument, Unamortized Discount, Current", "terseLabel": "Promissory notes payable, debt discount and debt issuance costs (in Dollars)" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r183", "r197", "r201", "r202", "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityCurrent": { "auth_ref": [ "r232", "r233" ], "calculation": { "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Compensation Liability, Current", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt Issuance Costs, Gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r183", "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Debt Issuance Costs, Net" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r42", "r43", "r44", "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Assets:" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r296" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Gain (Loss) on change in derivative liability" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r44", "r295", "r298", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable", "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable", "http://www.xsunx.com/role/WARRANTSTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liability", "verboseLabel": "Derivative Liability, Current" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r246", "r247", "r278", "r279", "r280", "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Share-Based Payment Arrangement [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r27", "r85", "r159", "r161", "r162", "r166", "r167", "r168", "r336" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r85", "r159", "r161", "r162", "r166", "r167", "r168", "r336", "r375", "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Due to Related Parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r52", "r93", "r94", "r95", "r96", "r97", "r101", "r104", "r109", "r110", "r111", "r114", "r115", "r303", "r304", "r377", "r387" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "BASIC INCOME (LOSS) PER SHARE (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r52", "r93", "r94", "r95", "r96", "r97", "r104", "r109", "r110", "r111", "r114", "r115", "r303", "r304", "r377", "r387" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "DILUTED INCOME (LOSS) PER SHARE (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r112", "r113" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "auth_ref": [ "r297" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.", "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "netLabel": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "terseLabel": "Derivative liability warrants", "verboseLabel": "Derivative Liability warrants at fair value" } } }, "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet", "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable", "http://www.xsunx.com/role/WARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative instrument embedded in host contract.", "label": "Embedded Derivative Financial Instruments [Member]", "terseLabel": "Embedded Derivative Financial Instruments [Member]" } } }, "localname": "EmbeddedDerivativeFinancialInstrumentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable", "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "domainItemType" }, "us-gaap_EmbeddedDerivativeLiabilityMeasurementInput": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure embedded derivative liability.", "label": "Embedded Derivative Liability, Measurement Input", "terseLabel": "Fair Value Measurement Input", "verboseLabel": "Embedded Derivative Liability, Measurement Input" } } }, "localname": "EmbeddedDerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "decimalItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r47", "r48", "r49", "r88", "r89", "r90", "r92", "r98", "r100", "r116", "r140", "r222", "r226", "r282", "r283", "r284", "r288", "r289", "r302", "r318", "r319", "r320", "r321", "r322", "r323", "r332", "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables", "http://www.xsunx.com/role/WARRANTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r185", "r201", "r202", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r306", "r347", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable", "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r185", "r235", "r236", "r241", "r243", "r306", "r347" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r185", "r201", "r202", "r235", "r236", "r241", "r243", "r306", "r348" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r185", "r201", "r202", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r306", "r349" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable", "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r311" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Extinguishment of derivatives" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r185", "r201", "r202", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r347", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r309", "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r309", "r312" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": { "auth_ref": [ "r310", "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings", "terseLabel": "Net (Gain)/Loss on change in fair value of derivative liability" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues": { "auth_ref": [ "r311", "r312" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues", "terseLabel": "Initial derivative liabilities" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": { "auth_ref": [ "r305", "r312" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueNetDerivativeAssetLiabilityMeasuredonRecurringBasisUnobservableInputReconciliationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments, Policy [Policy Text Block]" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Derivative Liability at fair value" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r295" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "negatedLabel": "Extinguishment of derivatives", "terseLabel": "Extinguishment of derivatives" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow", "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r70", "r205", "r206" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Extinguishment of debt", "terseLabel": "Extinguishment of debt", "verboseLabel": "Gain (Loss) on Extinguishment of Debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/ConsolidatedCashFlow", "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r67", "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "License fees payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses and interest on notes payable" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.", "label": "Increase (Decrease) in Deferred Liabilities", "terseLabel": "Deferred Compensation" } } }, "localname": "IncreaseDecreaseInDeferredLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Accrued payroll" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in Assets and Liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Other Accounts Payable", "terseLabel": "Other payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Employee advances" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r326" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "terseLabel": "Non-cash interest expense on bridge loan", "verboseLabel": "Interest Costs Capitalized" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r50", "r127", "r325", "r329", "r378" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r57", "r191", "r200", "r203", "r204" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest Expense, Debt" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CONVERTIBLELOANPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r63", "r66", "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses and interest on notes payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r395", "r397" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Investment Owned, Balance, Shares" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r70" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Stock issued and issuable for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r31", "r84", "r131", "r139", "r156", "r157", "r158", "r161", "r162", "r163", "r164", "r165", "r167", "r168", "r291", "r292", "r293", "r316", "r341", "r342" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r84", "r139", "r316", "r343", "r374", "r384" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r34", "r84", "r139", "r156", "r157", "r158", "r161", "r162", "r163", "r164", "r165", "r167", "r168", "r291", "r292", "r293", "r316", "r341", "r342", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r8", "r9", "r10", "r15", "r16", "r84", "r139", "r156", "r157", "r158", "r161", "r162", "r163", "r164", "r165", "r167", "r168", "r291", "r292", "r293", "r316", "r341", "r342" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r15", "r184", "r198", "r201", "r202", "r373", "r382" ], "calculation": { "http://www.xsunx.com/role/ScheduleofMaturitiesofLongtermDebtTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Convertible Promissory Notes", "totalLabel": "$" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofDebtTable", "http://www.xsunx.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "terseLabel": "Less current portion" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r86", "r155", "r189" ], "calculation": { "http://www.xsunx.com/role/ScheduleofMaturitiesofLongtermDebtTable": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Total long-term liabilities" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Measurement Input, Expected Dividend Rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/FairValueMeasurementInputsandValuationTechniquesTable", "http://www.xsunx.com/role/FairValueMeasurementsRecurringandNonrecurringValuationTechniquesTable" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r64" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r64", "r68", "r71" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r45", "r46", "r49", "r51", "r71", "r84", "r91", "r93", "r94", "r95", "r96", "r99", "r100", "r107", "r128", "r129", "r132", "r133", "r135", "r139", "r156", "r157", "r158", "r161", "r162", "r163", "r164", "r165", "r167", "r168", "r304", "r316", "r376", "r386" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "NET INCOME (LOSS)", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow", "http://www.xsunx.com/role/ConsolidatedIncomeStatement", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r93", "r94", "r95", "r96", "r101", "r102", "r108", "r111", "r128", "r129", "r132", "r133", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Loss to common shareholders (Numerator) (in Dollars)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ScheduleofEarningsPerShareBasicandDilutedTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "TOTAL OTHER INCOME/(EXPENSES)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "OTHER INCOME/(EXPENSES)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Promissory notes payable net of debt discount and debt issuance costs of $188,247 and $395,027, respectively" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r26", "r85", "r337" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Bridge Loans Payable - related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r85", "r336", "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "terseLabel": "Notes Payable, Related Parties" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r128", "r129", "r132", "r133", "r135" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "LOSS FROM OPERATIONS BEFORE OTHER INCOME/(EXPENSES)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r294" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ORGANIZATIONANDLINEOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "order": 6.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "License Fees Payable", "verboseLabel": "License fees payable" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet", "http://www.xsunx.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesAndSharesSubjectToMandatoryRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]" } } }, "localname": "OtherLiabilitiesAndSharesSubjectToMandatoryRedemptionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r32", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other payable" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Other Liabilities Disclosure [Text Block]" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Other Liabilities [Table Text Block]", "terseLabel": "Other Liabilities [Table Text Block]" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/DUETORELATEDPARTY" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLoansPayableCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term loans classified as other, payable within one year or the operating cycle, if longer.", "label": "Other Loans Payable, Current", "terseLabel": "Payable to TN3" } } }, "localname": "OtherLoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r61" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire preferred stock during the period.", "label": "Payments for Repurchase of Preferred Stock and Preference Stock", "negatedLabel": "Payments to TN3 for redemption of preferred stock" } } }, "localname": "PaymentsForRepurchaseOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Payments to Acquire Investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r18", "r223" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred Stock, Conversion Basis", "terseLabel": "Preferred Stock, Conversion Basis" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r208" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par (in Dollars per share)", "verboseLabel": "Preferred Stock, Par or Stated Value Per Share (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r208" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "verboseLabel": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Series B, $0.01 par value, 25,000 authorized 25,000 and 25,000 shares issued and outstanding, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r18", "r223" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred Stock, Voting Rights", "terseLabel": "Preferred Stock, Voting Rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r25", "r141", "r142" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r60" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Payments on convertible notes payable", "verboseLabel": "Proceeds from Convertible Debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails", "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r59" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Stock subscriptions received", "verboseLabel": "Proceeds from Issuance of Common Stock (in Dollars)" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.", "label": "Proceeds from Issuance of Convertible Preferred Stock", "terseLabel": "Proceeds from Issuance of Convertible Preferred Stock" } } }, "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLoans": { "auth_ref": [ "r65" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from principal payments made on loans related to operating activities.", "label": "Proceeds from Loans", "terseLabel": "Proceeds from bridge loans payable - related parties" } } }, "localname": "ProceedsFromLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r60" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from a note payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Proceeds from Other Debt" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r60" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from a related party loan", "verboseLabel": "Proceeds from Related Party Debt" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow", "http://www.xsunx.com/role/DUETORELATEDPARTYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds from (Repayments of) Related Party Debt", "terseLabel": "Due to related party" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Property, Plant and Equipment, Estimated Useful Life" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r145", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment [Table Text Block]" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, Plant and Equipment, Estimated Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r242", "r335", "r336" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/DUETORELATEDPARTYDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r335", "r338" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related Party Transaction, Amounts of Transaction (in Dollars)" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r242", "r335", "r338", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/DUETORELATEDPARTYDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r333", "r334", "r336", "r339", "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r62" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Payments on related party loan payable", "terseLabel": "Repayments of Debt (in Dollars)" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow", "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r62" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Payment on the bridge loans payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "terseLabel": "Repayments of Related Party Debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r287", "r357", "r404" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r226", "r343", "r383", "r393", "r394" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r88", "r89", "r90", "r92", "r98", "r100", "r140", "r282", "r283", "r284", "r288", "r289", "r302", "r390", "r392" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ACCOUNTSPAYABLEANDACCRUEDLIABILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt [Table Text Block]" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-Term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/PropertyPlantandEquipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r55" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r17", "r18", "r222" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r17", "r18", "r222" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r69" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Options Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SharebasedPaymentArrangementOptionExercisePriceRangeTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r247", "r248", "r249", "r251", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r250", "r270", "r271", "r272", "r273", "r276", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Payment Arrangement [Policy Text Block]" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Exercisable Prices (in Dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SharebasedPaymentArrangementOptionExercisePriceRangeTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Options Outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SharebasedPaymentArrangementOptionExercisePriceRangeTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SharebasedPaymentArrangementOptionExercisePriceRangeTable" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r228", "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "terseLabel": "Shareholders' Equity and Share-Based Payments [Text Block]" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/WARRANTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "Short-Term Debt [Text Block]", "terseLabel": "Short-Term Debt [Text Block]" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLELOANPAYABLE" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r79", "r87" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r17", "r18", "r19", "r81", "r84", "r104", "r105", "r106", "r109", "r111", "r117", "r118", "r119", "r139", "r156", "r161", "r162", "r163", "r167", "r168", "r208", "r209", "r212", "r216", "r222", "r316", "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r41", "r47", "r48", "r49", "r88", "r89", "r90", "r92", "r98", "r100", "r116", "r140", "r222", "r226", "r282", "r283", "r284", "r288", "r289", "r302", "r318", "r319", "r320", "r321", "r322", "r323", "r332", "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r116", "r358" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r75", "r76", "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Cash payable to TN3 for preferred stock" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r18", "r19", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Common Stock issued for StemVax acquisition - from stock payable (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r40", "r188", "r222", "r223", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Common Stock issued as repayment of loans (in Shares)", "verboseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Common Stock issued for services (in Shares)", "verboseLabel": "Stock Issued During Period, Shares, Issued for Services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r222", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "netLabel": "Stock Issued During Period, Shares, New Issues (in Shares)", "terseLabel": "Common Stock issued , subscriptions (in Shares)", "verboseLabel": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails", "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Common Stock issued as commitment fee on promissory note payable (in Shares)", "verboseLabel": "Stock Issued During Period, Shares, Other" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r222", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock compensation cost (in Shares)", "verboseLabel": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r41", "r222", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Common Stock issued for StemVax acquisition - from stock payable", "verboseLabel": "Shares issued for StemVax Acquisition \u2013 from stock payable" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r41", "r222", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Preferred Stock Redemption" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments", "terseLabel": "Common Stock issued as repayment of loans" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Common Stock issued for services", "verboseLabel": "Stock Issued During Period, Value, Issued for Services (in Dollars)" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r18", "r19", "r222", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Common Stock issued , subscriptions" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Common Stock issued as commitment fee on promissory note payable" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r226", "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r22", "r23", "r84", "r137", "r139", "r316", "r343" ], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "TOTAL SHAREHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet", "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "SHAREHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r82", "r209", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r226", "r228", "r301" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCK" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityOtherShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of increase (decrease) in shares of stock classified as other.", "label": "Stockholders' Equity, Other Shares", "terseLabel": "Stockholders' Equity, Other Shares" } } }, "localname": "StockholdersEquityOtherShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders' Equity, Reverse Stock Split", "terseLabel": "Stockholders' Equity, Reverse Stock Split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r324", "r345" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r324", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r344", "r346" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r120", "r121", "r122", "r123", "r124", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates, Policy [Policy Text Block]" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/WARRANTSTables" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r103", "r111" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average number of common shares outstanding (Denominator)", "verboseLabel": "DILUTED (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement", "http://www.xsunx.com/role/ScheduleofEarningsPerShareBasicandDilutedTable" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r101", "r111" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "BASIC (in Shares)", "terseLabel": "Basic weighted average number of common shares outstanding (Denominator)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement", "http://www.xsunx.com/role/ScheduleofEarningsPerShareBasicandDilutedTable" ], "xbrltype": "sharesItemType" }, "xsnx_AccruedInterestCapitalizedIntoConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest costs capitalized,", "label": "Accrued interest capitalized into convertible note" } } }, "localname": "AccruedInterestCapitalizedIntoConvertibleNote", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "xsnx_AdditionalPaidInCapitalCommonStockWarrants": { "auth_ref": [], "calculation": { "http://www.xsunx.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from common stock warrant related transactions that are in excess of par value or stated value and amounts received from other warrant-related transactions. Includes only common stock warrant transactions.", "label": "AdditionalPaidInCapitalCommonStockWarrants", "terseLabel": "Paid in capital, common stock warrants" } } }, "localname": "AdditionalPaidInCapitalCommonStockWarrants", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "xsnx_AdditionalPaidInCapitalPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional paid in capital on preferred stock.", "label": "AdditionalPaidInCapitalPreferredStockMember", "terseLabel": "Additional Paid in Capital Preferred Stock [Member]" } } }, "localname": "AdditionalPaidInCapitalPreferredStockMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "xsnx_AdditionalPaidInCapitalStockOptionsWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about additional paid in capital stock options and warrants.", "label": "AdditionalPaidInCapitalStockOptionsWarrantsMember", "terseLabel": "Additional Paid in Capital Stock Options / Warrants [Member]" } } }, "localname": "AdditionalPaidInCapitalStockOptionsWarrantsMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "xsnx_AgreementMonthlyAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Monthly amount per agreement.", "label": "AgreementMonthlyAmount", "terseLabel": "Agreement, Monthly Amount" } } }, "localname": "AgreementMonthlyAmount", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "xsnx_AgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of agreement.", "label": "AgreementTerm", "terseLabel": "Agreement, Term" } } }, "localname": "AgreementTerm", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "xsnx_AugustNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of debt instrument.", "label": "AugustNoteMember", "terseLabel": "August Note [Member]" } } }, "localname": "AugustNoteMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "xsnx_BRIDGELOANSPAYABLERELATEDPARTIESDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Line Items]" } } }, "localname": "BRIDGELOANSPAYABLERELATEDPARTIESDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "stringItemType" }, "xsnx_BRIDGELOANSPAYABLERELATEDPARTIESDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BRIDGE LOANS PAYABLE - RELATED PARTIES (Details) [Table]" } } }, "localname": "BRIDGELOANSPAYABLERELATEDPARTIESDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "stringItemType" }, "xsnx_CAPITALSTOCKDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL STOCK (Details) [Line Items]" } } }, "localname": "CAPITALSTOCKDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "stringItemType" }, "xsnx_CAPITALSTOCKDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL STOCK (Details) [Table]" } } }, "localname": "CAPITALSTOCKDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails" ], "xbrltype": "stringItemType" }, "xsnx_CEOAndCFOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CEOAndCFOMember", "terseLabel": "CEO and CFO [Member]" } } }, "localname": "CEOAndCFOMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/BRIDGELOANSPAYABLERELATEDPARTIESDetails" ], "xbrltype": "domainItemType" }, "xsnx_CONVERTIBLEPROMISSORYNOTESDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE PROMISSORY NOTES (Details) [Line Items]" } } }, "localname": "CONVERTIBLEPROMISSORYNOTESDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "stringItemType" }, "xsnx_CONVERTIBLEPROMISSORYNOTESDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE PROMISSORY NOTES (Details) [Table]" } } }, "localname": "CONVERTIBLEPROMISSORYNOTESDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "stringItemType" }, "xsnx_CONVERTIBLEPROMISSORYNOTESTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE PROMISSORY NOTES (Tables) [Line Items]" } } }, "localname": "CONVERTIBLEPROMISSORYNOTESTablesLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "stringItemType" }, "xsnx_CONVERTIBLEPROMISSORYNOTESTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE PROMISSORY NOTES (Tables) [Table]" } } }, "localname": "CONVERTIBLEPROMISSORYNOTESTablesTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESTables" ], "xbrltype": "stringItemType" }, "xsnx_ClassOfWarrantOrRightsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate amount of each class of warrants or rights granted.", "label": "ClassOfWarrantOrRightsGranted", "terseLabel": "Class of Warrant or Rights, Granted" } } }, "localname": "ClassOfWarrantOrRightsGranted", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/WARRANTSDetails" ], "xbrltype": "sharesItemType" }, "xsnx_CommonStockIssuableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStockIssuableMember", "terseLabel": "Common Stock Issuable [Member]" } } }, "localname": "CommonStockIssuableMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "xsnx_ConvertibleNotePayableOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "ConvertibleNotePayableOneMember", "terseLabel": "Convertible Note Payable One [Member]" } } }, "localname": "ConvertibleNotePayableOneMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "xsnx_ConvertibleNotePayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "ConvertibleNotePayableTwoMember", "terseLabel": "Convertible Note Payable Two [Member]" } } }, "localname": "ConvertibleNotePayableTwoMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "xsnx_DUETORELATEDPARTYDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DUE TO RELATED PARTY (Details) [Line Items]" } } }, "localname": "DUETORELATEDPARTYDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/DUETORELATEDPARTYDetails" ], "xbrltype": "stringItemType" }, "xsnx_DUETORELATEDPARTYDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DUE TO RELATED PARTY (Details) [Table]" } } }, "localname": "DUETORELATEDPARTYDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/DUETORELATEDPARTYDetails" ], "xbrltype": "stringItemType" }, "xsnx_DebtDefaultInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Default interest rate.", "label": "DebtDefaultInterestRate", "terseLabel": "Debt, Default Interest Rate" } } }, "localname": "DebtDefaultInterestRate", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "percentItemType" }, "xsnx_DebtOriginalIssueDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Original issue discount rate.", "label": "DebtOriginalIssueDiscountRate", "terseLabel": "Debt, Original Issue Discount Rate" } } }, "localname": "DebtOriginalIssueDiscountRate", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "percentItemType" }, "xsnx_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_FairValueMeasurementInputsAndValuationTechniquesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]" } } }, "localname": "FairValueMeasurementInputsAndValuationTechniquesAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_FairValueMeasurementsRecurringAndNonrecurringValuationTechniquesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Abstract]" } } }, "localname": "FairValueMeasurementsRecurringAndNonrecurringValuationTechniquesAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_FebruaryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FebruaryNoteMember", "terseLabel": "February Note [Member]" } } }, "localname": "FebruaryNoteMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "xsnx_GainLossOnConversionOfDebtAndChangeInDerivativeLiability": { "auth_ref": [], "calculation": { "http://www.xsunx.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain (loss) recognized on the conversion of debt and change in derivative liability.", "label": "GainLossOnConversionOfDebtAndChangeInDerivativeLiability", "negatedLabel": "(Gain)/Loss on change in derivative liability" } } }, "localname": "GainLossOnConversionOfDebtAndChangeInDerivativeLiability", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "xsnx_ImputedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Imputed interest.", "label": "ImputedInterest", "terseLabel": "Imputed Interest" } } }, "localname": "ImputedInterest", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/DUETORELATEDPARTYDetails" ], "xbrltype": "monetaryItemType" }, "xsnx_IrvinConsultingLLCICMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IrvinConsultingLLCICMember", "terseLabel": "Irvin Consulting, LLC (\"IC\") [Member]" } } }, "localname": "IrvinConsultingLLCICMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "xsnx_JulyNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of debt instrument.", "label": "JulyNoteMember", "terseLabel": "July Note [Member]" } } }, "localname": "JulyNoteMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "xsnx_JuneNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of debt instrument.", "label": "JuneNoteMember", "terseLabel": "June Note [Member]" } } }, "localname": "JuneNoteMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CONVERTIBLEPROMISSORYNOTESDetails" ], "xbrltype": "domainItemType" }, "xsnx_LongTermLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LongTermLiabilitiesAbstract", "terseLabel": "LONG TERM LIABILITIES" } } }, "localname": "LongTermLiabilitiesAbstract", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "xsnx_OPTIONSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPTIONS (Details) [Line Items]" } } }, "localname": "OPTIONSDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "stringItemType" }, "xsnx_OPTIONSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPTIONS (Details) [Table]" } } }, "localname": "OPTIONSDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "stringItemType" }, "xsnx_OptionPostStockSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OptionPostStockSplitMember", "terseLabel": "Option Post Stock Split [Member]" } } }, "localname": "OptionPostStockSplitMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/OPTIONSDetails" ], "xbrltype": "domainItemType" }, "xsnx_PreferredStock50000000SharesAuthorizedSharesIssuedAndOutstandingDesignatedAsFollowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PreferredStock50000000SharesAuthorizedSharesIssuedAndOutstandingDesignatedAsFollowsAbstract", "terseLabel": "Preferred stock 50,000,000 shares authorized, shares issued and outstanding designated as follows:" } } }, "localname": "PreferredStock50000000SharesAuthorizedSharesIssuedAndOutstandingDesignatedAsFollowsAbstract", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "xsnx_RELATEDPARTYTRANSACTIONSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS (Details) [Line Items]" } } }, "localname": "RELATEDPARTYTRANSACTIONSDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "xsnx_RELATEDPARTYTRANSACTIONSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS (Details) [Table]" } } }, "localname": "RELATEDPARTYTRANSACTIONSDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "xsnx_SUBSEQUENTEVENTSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS (Details) [Line Items]" } } }, "localname": "SUBSEQUENTEVENTSDetailsLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "xsnx_SUBSEQUENTEVENTSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS (Details) [Table]" } } }, "localname": "SUBSEQUENTEVENTSDetailsTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "xsnx_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]" } } }, "localname": "SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "stringItemType" }, "xsnx_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table]" } } }, "localname": "SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" ], "xbrltype": "stringItemType" }, "xsnx_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities [Abstract]" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_ScheduleOfDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Abstract]" } } }, "localname": "ScheduleOfDebtAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_ScheduleOfEarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Abstract]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_ScheduleOfMaturitiesOfLongTermDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Maturities of Long-term Debt [Abstract]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_ShareBasedPaymentArrangementOptionExercisePriceRangeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Abstract]" } } }, "localname": "ShareBasedPaymentArrangementOptionExercisePriceRangeAbstract", "nsuri": "http://www.xsunx.com/20220331", "xbrltype": "stringItemType" }, "xsnx_TN3LLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TN3LLCMember", "terseLabel": "TN3, LLC [Member]" } } }, "localname": "TN3LLCMember", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/CAPITALSTOCKDetails", "http://www.xsunx.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "xsnx_WARRANTSTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANTS (Tables) [Line Items]" } } }, "localname": "WARRANTSTablesLineItems", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/WARRANTSTables" ], "xbrltype": "stringItemType" }, "xsnx_WARRANTSTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANTS (Tables) [Table]" } } }, "localname": "WARRANTSTablesTable", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/WARRANTSTables" ], "xbrltype": "stringItemType" }, "xsnx_WeightedAverageCommonSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WeightedAverageCommonSharesOutstandingAbstract", "terseLabel": "WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING" } } }, "localname": "WeightedAverageCommonSharesOutstandingAbstract", "nsuri": "http://www.xsunx.com/20220331", "presentation": [ "http://www.xsunx.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126974470&loc=d3e8622-111531" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r154": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r286": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r294": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r346": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.2)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r405": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r406": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r407": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r408": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r409": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r411": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" } }, "version": "2.1" } ZIP 62 0001185185-22-000616-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001185185-22-000616-xbrl.zip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�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end